61 Functionalized and Structured Medical Wire as a Device for In-vivo Isolation of Circulating Tumor Cells in Breast Cancer Patients (English)
- New search for: Nowaczyk, P.
- New search for: Herold, S.
- New search for: Kim, P. S.
- New search for: Schmitz, A.
- New search for: Polom, K.
- New search for: Murawa, P.
- New search for: Morgenthaler, N. G.
- New search for: Zabel, M.
- New search for: Luecke, K.
- New search for: Murawa, D.
- New search for: Nowaczyk, P.
- New search for: Herold, S.
- New search for: Kim, P. S.
- New search for: Schmitz, A.
- New search for: Polom, K.
- New search for: Murawa, P.
- New search for: Morgenthaler, N. G.
- New search for: Zabel, M.
- New search for: Luecke, K.
- New search for: Murawa, D.
In:
Abstract Book EBCC8 - European Breast Cancer Conference
;
S58-S59
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:61 Functionalized and Structured Medical Wire as a Device for In-vivo Isolation of Circulating Tumor Cells in Breast Cancer Patients
-
Contributors:Nowaczyk, P. ( author ) / Herold, S. ( author ) / Kim, P. S. ( author ) / Schmitz, A. ( author ) / Polom, K. ( author ) / Murawa, P. ( author ) / Morgenthaler, N. G. ( author ) / Zabel, M. ( author ) / Luecke, K. ( author ) / Murawa, D. ( author )
-
Published in:EUROPEAN JOURNAL OF CANCER ; 48 ; S58-S59
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2012-01-01
-
Size:S58-S59
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 48
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
A comparison of international breast cancer guidelines - Do the national guidelines differ in treatment recommendations?Wolters, R. / Regierer, A. C. / Schwentner, L. / Geyer, V. / Possinger, K. / Kreienberg, R. / Wischnewsky, M. B. / Wockel, A. et al. | 2012
- 12
-
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentationKarn, T. / Pusztai, L. / Ruckhaberle, E. / Liedtke, C. / Muller, V. / Schmidt, M. / Metzler, D. / Wang, J. / Coombes, K. R. / Gatje, R. et al. | 2012
- 24
-
Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancerFedele, P. / Marino, A. / Orlando, L. / Schiavone, P. / Nacci, A. / Sponziello, F. / Rizzo, P. / Calvani, N. / Mazzoni, E. / Cinefra, M. et al. | 2012
- 30
-
Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: An external validation studyBendifallah, S. / Defert, S. / Chabbert-Buffet, N. / Maurin, N. / Chopier, J. / Antoine, M. / Bezu, C. / Touche, D. / Uzan, S. / Graesslin, O. et al. | 2012
- 37
-
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trialKennecke, H. / Berry, S. / Wong, R. / Zhou, C. / Tankel, K. / Easaw, J. / Rao, S. / Post, J. / Hay, J. et al. | 2012
- 46
-
Colorectal cancer survival in socioeconomic groups in England: Variation is mainly in the short term after diagnosisMoller, H. / Sandin, F. / Robinson, D. / Bray, F. / Klint, a. / Linklater, K. M. / Lambert, P. C. / Pahlman, L. / Holmberg, L. / Morris, E. et al. | 2012
- 54
-
Variation in surgical resection for lung cancer in relation to survival: Population-based study in England 2004-2006Riaz, S. P. / Luchtenborg, M. / Jack, R. H. / Coupland, V. H. / Linklater, K. M. / Peake, M. D. / Moller, H. et al. | 2012
- 61
-
Establishing an EGFR mutation screening service for non-small cell lung cancer - Sample quality criteria and candidate histological predictorsLeary, A. F. / Castro, D. G. / Nicholson, A. G. / Ashley, S. / Wotherspoon, A. / O'Brien, M. E. / Popat, S. et al. | 2012
- 68
-
A phase II study of 18F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva); objective and symptomatic responses at 6 and 12weeksO'Brien, M. E. / Myerson, J. S. / Coward, J. I. / Puglisi, M. / Trani, L. / Wotherspoon, A. / Sharma, B. / Cook, G. / Ashley, S. / Gunapala, R. et al. | 2012
- 75
-
Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancerBerglund, A. / Garmo, H. / Robinson, D. / Tishelman, C. / Holmberg, L. / Bratt, O. / Adolfsson, J. / Stattin, P. / Lambe, M. et al. | 2012
- 85
-
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancerFizazi, K. / De Bono, J. S. / Flechon, A. / Heidenreich, A. / Voog, E. / Davis, N. B. / Qi, M. / Bandekar, R. / Vermeulen, J. T. / Cornfeld, M. et al. | 2012
- 94
-
Prevalence of BRAF V600E mutation in Chinese melanoma patients: Large scale analysis of BRAF and NRAS mutations in a 432-case cohortSi, L. / Kong, Y. / Xu, X. / Flaherty, K. T. / Sheng, X. / Cui, C. / Chi, Z. / Li, S. / Mao, L. / Guo, J. et al. | 2012
- 101
-
Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: The AnemOnHe studySpielmann, M. / Luporsi, E. / Ray-Coquard, I. / de Botton, S. / Azria, D. / Lasocki, S. / Lafuma, A. / Mahi, L. / Deray, G. / Bugat, R. et al. | 2012
- 108
-
Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone - The results of the United Kingdom HD3 national cohort trialShankar, A. / Visaduraki, M. / Hayward, J. / Morland, B. / McCarthy, K. / Hewitt, M. et al. | 2012
- 114
-
Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritisFrank, B. / Weck, M. N. / Muller, H. / Klopp, N. / Illig, T. / Raum, E. / Brenner, H. et al. | 2012
- 121
-
Risk of coronary heart disease in patients with cancer: A nationwide follow-up study from SwedenZoller, B. / Ji, J. / Sundquist, J. / Sundquist, K. et al. | 2012
- 129
-
Human adipose tissue-derived mesenchymal stem cells: Characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomasChoi, S. A. / Lee, J. Y. / Wang, K. C. / Phi, J. H. / Song, S. H. / Song, J. / Kim, S. K. et al. | 2012
- 138
-
CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cellsMonnier, J. / Boissan, M. / L'Helgoualc'h, A. / Lacombe, M. L. / Turlin, B. / Zucman-Rossi, J. / Theret, N. / Piquet-Pellorce, C. / Samson, M. et al. | 2012
- 149
-
The catalytic phosphoinositol 3-kinase isoform p110d is required for glioma cell migration and invasionLuk, S. K. / Piekorz, R. P. / Nurnberg, B. / Tony To, S. S. et al. | 2012
- 159
-
Burden of testicular, paratesticular and extragonadal germ cell tumours in EuropeTrama, A. / Mallone, S. / Nicolai, N. / Necchi, A. / Schaapveld, M. / Gietema, J. / Znaor, A. / Ardanaz, E. / Berrino, F. et al. | 2012
- 170
-
Targeted agents: How to select the winners in preclinical and early clinical studies?Goodwin, R. / Giaccone, G. / Calvert, H. / Lobbezoo, M. / Eisenhauer, E. A. et al. | 2012
- 179
-
A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumoursSchoffski, P. / Awada, A. / Dumez, H. / Gil, T. / Bartholomeus, S. / Wolter, P. / Taton, M. / Fritsch, H. / Glomb, P. / Munzert, G. et al. | 2012
- 187
-
The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trialsYan, T. / Yin, W. / Zhou, Q. / Zhou, L. / Jiang, Y. / Du, Y. / Shao, Z. / Lu, J. et al. | 2012
- 196
-
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational studyYi, J. H. / Thongprasert, S. / Lee, J. / Doval, D. C. / Park, S. H. / Park, J. O. / Park, Y. S. / Kang, W. K. / Lim, H. Y. et al. | 2012
- 202
-
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinomaKeizman, D. / Ish-Shalom, M. / Huang, P. / Eisenberger, M. A. / Pili, R. / Hammers, H. / Carducci, M. A. et al. | 2012
- 209
-
A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: A planned analysis of response, toxicity and quality of life in the GETUG 12 trialFizazi, K. / Lesaunier, F. / Delva, R. / Gravis, G. / Rolland, F. / Priou, F. / Ferrero, J. M. / Houede, N. / Mourey, L. / Theodore, C. et al. | 2012
- 218
-
Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991Eggermont, A. M. / Suciu, S. / Testori, A. / Kruit, W. H. / Marsden, J. / Punt, C. J. / Santinami, M. / Sales, F. / Schadendorf, D. / Patel, P. et al. | 2012
- 226
-
Decision-making in the end-of-life phase of high-grade glioma patientsSizoo, E. M. / Pasman, H. R. / Buttolo, J. / Heimans, J. J. / Klein, M. / Deliens, L. / Reijneveld, J. C. / Taphoorn, M. J. et al. | 2012
- 233
-
Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemiaPreuner, S. / Mitterbauer, G. / Mannhalter, C. / Herndlhofer, S. / Sperr, W. R. / Valent, P. / Lion, T. et al. | 2012
- 237
-
The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human UseHanaizi, Z. / van Zwieten-Boot, B. / Calvo, G. / Lopez, A. S. / van Dartel, M. / Camarero, J. / Abadie, E. / Pignatti, F. et al. | 2012
- 243
-
Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: A perspective from Central AmericaSala, A. / Rossi, E. / Antillon, F. / Molina, A. L. / de Maselli, T. / Bonilla, M. / Hernandez, A. / Ortiz, R. / Pacheco, C. / Nieves, R. et al. | 2012
- 253
-
Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcomaGeoerger, B. / Kieran, M. W. / Grupp, S. / Perek, D. / Clancy, J. / Krygowski, M. / Ananthakrishnan, R. / Boni, J. P. / Berkenblit, A. / Spunt, S. L. et al. | 2012
- 263
-
Survival from childhood acute lymphoblastic leukaemia: the impact of social inequality in the United KingdomLightfoot, T. J. / Johnston, W. T. / Simpson, J. / Smith, A. G. / Ansell, P. / Crouch, S. / Roman, E. / Kinsey, S. E. et al. | 2012
- 270
-
How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006Ellis, L. / Coleman, M. P. / Rachet, B. et al. | 2012
- 279
-
Hepatotoxicity associated with lapatinib in an experimental rat modelDemirci, U. / Buyukberber, S. / Ylmaz, G. / Kerem, M. / Coskun, U. / Uner, A. / Baykara, M. / Pasali, H. / Benekli, M. et al. | 2012
- 287
-
Corrigendum to "Can allogeneic peripheral blood stem cells be safely cryopreserved for use in patients undergoing transplant" [Eur. J. Cancer 47 (S1) (2011) S648]Patel, M. / Webber, M. et al. | 2012
- 289
-
A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) studyGeoerger, B. / Estlin, E. J. / Aerts, I. / Kearns, P. / Gibson, B. / Corradini, N. / Doz, F. / Lardelli, P. / Miguel, B. D. / Soto, A. et al. | 2012
- 297
-
Physical activity in a German breast cancer patient cohort: One-year trends and characteristics associated with change in activity levelHuy, C. / Schmidt, M. E. / Vrieling, A. / Chang-Claude, J. / Steindorf, K. et al. | 2012
- 305
-
Tetraploidy in BRCA2 breast tumoursJonsdottir, A. B. / Stefansson, O. A. / Bjornsson, J. / Jonasson, J. G. / Ogmundsdottir, H. M. / Eyfjord, J. E. et al. | 2012
- 311
-
Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trialCella, D. / Pickard, A. S. / Duh, M. S. / Guerin, A. / Mishagina, N. / Antras, L. / Neary, M. P. / McCann, L. / Hodge, R. / Sternberg, C. N. et al. | 2012
- 324
-
An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapyGrunwald, V. / Karakiewicz, P. I. / Bavbek, S. E. / Miller, K. / Machiels, J. P. / Lee, S. H. / Larkin, J. / Bono, P. / Rha, S. Y. / Castellano, D. et al. | 2012
- 333
-
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 studyCalvo, E. / Escudier, B. / Motzer, R. J. / Oudard, S. / Hutson, T. E. / Porta, C. / Bracarda, S. / Grunwald, V. / Thompson, J. A. / Ravaud, A. et al. | 2012
- 340
-
The risk of skin rash and stomatitis with the mammalian target of rapamycin inhibitor temsirolimus: A systematic review of the literature and meta-analysisGomez-Fernandez, C. / Garden, B. C. / Wu, S. / Feldman, D. R. / Lacouture, M. E. et al. | 2012
- 347
-
Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: A national multicentre studyRiber-Hansen, R. / Hastrup, N. / Clemmensen, O. / Behrendt, N. / Klausen, S. / Ramsing, M. / Spaun, E. / Hamilton-Dutoit, S. J. / Steiniche, T. et al. | 2012
- 353
-
Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experienceLafay-Cousin, L. / Hawkins, C. / Carret, A. S. / Johnston, D. / Zelcer, S. / Wilson, B. / Jabado, N. / Scheinemann, K. / Eisenstat, D. / Fryer, C. et al. | 2012
- 360
-
The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: A joint analysis of five randomised trials on behalf of the EWALLGiebel, S. / Thomas, X. / Hallbook, H. / Geissler, K. / Boiron, J. M. / Huguet, F. / Koller, E. / Jaeger, U. / Smedmyr, B. / Hellmann, A. et al. | 2012
- 368
-
Evolution of requests to hasten death among patients managed by palliative care teams in France: A multicentre cross-sectional survey (DemandE)Ferrand, E. / Dreyfus, J. F. / Chastrusse, M. / Ellien, F. / Lemaire, F. / Fischler, M. et al. | 2012
- 377
-
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)Pesce, G. A. / Klingbiel, D. / Ribi, K. / Zouhair, A. / von Moos, R. / Schlaeppi, M. / Caspar, C. B. / Fischer, N. / Anchisi, S. / Peters, S. et al. | 2012
- 385
-
Poor correlation between progression-free and overall survival in modern clinical trials: Are composite endpoints the answer?Amir, E. / Seruga, B. / Kwong, R. / Tannock, I. F. / Ocana, A. et al. | 2012
- 389
-
Targeting Raf/MEK/ERK pathway in pituitary adenomasSuojun, Z. / Feng, W. / Dongsheng, G. / Ting, L. et al. | 2012
- 396
-
The phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 is effective in inhibiting regrowth of tumour cells after cytotoxic therapyHernlund, E. / Olofsson, M. H. / Fayad, W. / Fryknas, M. / Lesiak-Mieczkowska, K. / Zhang, X. / Brnjic, S. / Schmidt, V. / D'Arcy, P. / Sjoblom, T. et al. | 2012
- 407
-
Corrigendum to ''Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis'' [Eur J Cancer 47 (12) (2011) 1826-1836]Clarke, S. J. / Yip, S. / Brown, C. / van Hazel, G. A. / Ransom, D. T. / Goldstein, D. / Mark Jeffrey, G. / Tebbutt, N. C. / Buck, M. / Lowenthal, R. M. et al. | 2012
- 409
-
Qualification of imaging biomarkers for oncology drug developmentWaterton, J. C. / Pylkkanen, L. et al. | 2012
- 416
-
[^1^8F]FLT: An imaging biomarker of tumour proliferation for assessment of tumour response to treatmentSoloviev, D. / Lewis, D. / Honess, D. / Aboagye, E. et al. | 2012
- 425
-
Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug developmentSinkus, R. / Van Beers, B. E. / Vilgrain, V. / DeSouza, N. / Waterton, J. C. et al. | 2012
- 432
-
Imaging apoptosis with positron emission tomography: 'Bench to bedside' development of the caspase-3/7 specific radiotracer [^1^8F]ICMT-11Nguyen, Q. D. / Challapalli, A. / Smith, G. / Fortt, R. / Aboagye, E. O. et al. | 2012
- 441
-
Radiomics: Extracting more information from medical images using advanced feature analysisLambin, P. / Rios-Velazquez, E. / Leijenaar, R. / Carvalho, S. / van Stiphout, R. G. P. M. / Granton, P. / Zegers, C. M. L. / Gillies, R. / Boellard, R. / Dekker, A. et al. | 2012
- 447
-
Quantifying heterogeneity in human tumours using MRI and PETAsselin, M. C. / O'Connor, J. P. B. / Boellaard, R. / Thacker, N. A. / Jackson, A. et al. | 2012
- 456
-
Incidence and survival of rare urogenital cancers in EuropeThe RARECARE working group / Visser, O. / Adolfsson, J. / Rossi, S. / Verne, J. / Gatta, G. / Maffezzini, M. / Franks, K. N. et al. | 2012
- 465
-
Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumoursAwada, A. / Hendlisz, A. / Christensen, O. / Lathia, C. D. / Bartholomeus, S. / Lebrun, F. / de Valeriola, D. / Brendel, E. / Radtke, M. / Delaunoit, T. et al. | 2012
- 475
-
Safety of bevacizumab in metastatic breast cancer patients undergoing surgeryCortes, J. / Caralt, M. / Delaloge, S. / Cortes-Funes, H. / Pierga, J. Y. / Pritchard, K. I. / Bollag, D. T. / Miles, D. W. et al. | 2012
- 482
-
Combining capecitabine and bevacizumab in metastatic breast cancer: A comprehensive reviewMiles, D. / Zielinski, C. / Martin, M. / Vrdoljak, E. / Robert, N. et al. | 2012
- 492
-
Venous thromboembolism (VTE) in patients with advanced gastric cancer: An Asian experienceKang, M. J. / Ryoo, B. Y. / Ryu, M. H. / Koo, D. H. / Chang, H. M. / Lee, J. L. / Kim, T. W. / Kang, Y. K. et al. | 2012
- 501
-
Mucinous adenocarcinomas: Poor prognosis in metastatic colorectal cancerMekenkamp, L. J. M. / Heesterbeek, K. J. / Koopman, M. / Tol, J. / Teerenstra, S. / Venderbosch, S. / Punt, C. J. A. / Nagtegaal, I. D. et al. | 2012
- 510
-
Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancerSchonnemann, K. R. / Yilmaz, M. / Bjerregaard, J. K. / Nielsen, K. M. / Pfeiffer, P. et al. | 2012
- 518
-
A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancerKim, G. M. / Jeung, H. C. / Rha, S. Y. / Kim, H. S. / Jung, I. / Nam, B. H. / Lee, K. H. / Chung, H. C. et al. | 2012
- 527
-
Cediranib monotherapy in patients with advanced renal cell carcinoma: Results of a randomised phase II studyMulders, P. / Hawkins, R. / Nathan, P. / de Jong, I. / Osanto, S. / Porfiri, E. / Protheroe, A. / van Herpen, C. M. L. / Mookerjee, B. / Pike, L. et al. | 2012
- 538
-
ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortalityBismar, T. A. / Dolph, M. / Teng, L. H. / Liu, S. / Donnelly, B. et al. | 2012
- 547
-
First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-label and double-blind studyDemetri, G. D. / Le Cesne, A. / Chawla, S. P. / Brodowicz, T. / Maki, R. G. / Bach, B. A. / Smethurst, D. P. / Bray, S. / Hei, Y. j. / Blay, J. Y. et al. | 2012
- 564
-
A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcomaDuffaud, F. / Egerer, G. / Ferrari, S. / Rassam, H. / Boecker, U. / Bui-Nguyen, B. et al. | 2012
- 571
-
Sexuality and body image in long-term survivors of testicular cancerRossen, P. / Pedersen, A. F. / Zachariae, R. / von der Maase, H. et al. | 2012
- 579
-
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology GroupBaruchel, S. / Pappo, A. / Krailo, M. / Baker, K. S. / Wu, B. / Villaluna, D. / Lee-Scott, M. / Adamson, P. C. / Blaney, S. M. et al. | 2012
- 586
-
Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancerSorensen, H. T. / Svaerke, C. / Farkas, D. K. / Christiansen, C. F. / Pedersen, L. / Lash, T. L. / Prandoni, P. / Baron, J. A. et al. | 2012
- 594
-
Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for Phase I oncology trial participants - Reply to Fussenich et al.: A new, simple and objective prognostic score for Phase I cancer patientson behalf of the EDDN / Olmos, D. / Ang, J. E. / Gomez-Roca, C. / Morales-Barrera, R. / Vulink, A. J. / Massard, C. / Kaye, S. et al. | 2012
- 597
-
Reply letter to: Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participant - Reply to Fussenich et al.: A new, simple and objective prognostic score for phase I cancer patientsvan Herpen, C. M. L. / Teerenstra, S. / Desar, I. M. E. / van der Graaf, W. T. A. et al. | 2012
- 599
-
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma| 2012
- 642
-
Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experienceAdamo, V. / Ricciardi, G. R. R. / De Placido, S. / Colucci, G. / Conte, P. / Giuffrida, D. / Gebbia, N. / Masci, G. / Cognetti, F. / Dondi, D. et al. | 2012
- 648
-
Trucut biopsy of breast lesions: The first step toward international standards in developing countriesJoulaee, A. / Kalantari, M. / Kadivar, M. / Joulaee, S. / Bahrani, N. / Mangual, M. / Hosseini, Sh. / Etemadmoghadam, Gh. et al. | 2012
- 655
-
Chewing areca nut, betel quid, oral snuff, cigarette smoking and the risk of oesophageal squamous-cell carcinoma in South Asians: A multicentre case-control studyAkhtar, S. / Sheikh, A. A. / Qureshi, H. U. et al. | 2012
- 662
-
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragmentsKorse, C. M. / Taal, B. G. / Vincent, A. / van Velthuysen, M. L. F. / Baas, P. / Buning-Kager, J. C. G. M. / Linders, T. C. / Bonfrer, J. M. G. et al. | 2012
- 672
-
A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancerKawaguchi, T. / Takada, M. / Ando, M. / Okishio, K. / Atagi, S. / Fujita, Y. / Tomizawa, Y. / Hayashihara, K. / Okano, Y. / Takahashi, F. et al. | 2012
- 678
-
A Randomized, Dose-Response, Multicenter Phase II Study of Radium-223 chloride for the Palliation of Painful Bone Metastases in Patients With Castration-Resistant Prostate CancerNilsson, S. / Strang, P. / Aksnes, A. K. / Franzen, L. / Olivier, P. / Pecking, A. / Staffurth, J. / Vasanthan, S. / Andersson, C. / Bruland, O. S. et al. | 2012
- 687
-
Primary versus secondary cytoreduction for epithelial ovarian cancer: A paired analysis of tumour pattern and surgical outcomeBraicu, E. I. / Sehouli, J. / Richter, R. / Pietzner, K. / Lichtenegger, W. / Fotopoulou, C. et al. | 2012
- 695
-
Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanomaEgberts, F. / Kotthoff, E. M. / Gerdes, S. / Egberts, J. H. / Weichenthal, M. / Hauschild, A. et al. | 2012
- 703
-
Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma IntergroupMcTiernan, A. / Jinks, R. C. / Sydes, M. R. / Uscinska, B. / Hook, J. M. / van Glabbeke, M. / Bramwell, V. / Lewis, I. J. / Taminiau, A. H. M. / Nooij, M. A. et al. | 2012
- 713
-
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)Sebban, C. / Lefranc, A. / Perrier, L. / Moreau, P. / Espinouse, D. / Schmidt, A. / Kammoun, L. / Ghesquieres, H. / Ferlay, C. / Bay, J. O. et al. | 2012
- 721
-
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trialGross-Goupil, M. / Fourcade, A. / Blot, E. / Penel, N. / Negrier, S. / Culine, S. / Chaigneau, L. / Lesimple, T. / Priou, F. / Lortholary, A. et al. | 2012
- 728
-
Child maltreatment and breast cancer survivors: Social support makes a difference for quality of life, fatigue and cancer stressFagundes, C. P. / Lindgren, M. E. / Shapiro, C. L. / Kiecolt-Glaser, J. K. et al. | 2012
- 737
-
Merkel cell carcinoma - A population-based epidemiological study in Finland with a clinical series of 181 casesKukko, H. / Bohling, T. / Koljonen, V. / Tukiainen, E. / Haglund, C. / Pokhrel, A. / Sankila, R. / Pukkala, E. et al. | 2012
- 743
-
Determinants of successful implementation of population-based cancer screening programmesLynge, E. / Tornberg, S. / von Karsa, L. / Segnan, N. / van Delden, J. J. M. et al. | 2012
- 749
-
The risk of oesophageal adenocarcinoma after gastrectomy for peptic ulcer diseaseLagergren, J. / Lindam, A. et al. | 2012
- 753
-
Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesisHerath, N. I. / Spanevello, M. D. / Doecke, J. D. / Smith, F. M. / Pouponnot, C. / Boyd, A. W. et al. | 2012
- 763
-
Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expressionLamers, F. / Schild, L. / Koster, J. / Versteeg, R. / Caron, H. N. / Molenaar, J. J. et al. | 2012
- 772
-
Aquaporin-4 expression in primary human central nervous system lymphomas correlates with tumour cell proliferation and phenotypic heterogeneity of the vessel wallNico, B. / Annese, T. / Tamma, R. / Longo, V. / Ruggieri, S. / Senetta, R. / Cassoni, P. / Specchia, G. / Vacca, A. / Ribatti, D. et al. | 2012
- 783
-
Rare cancers of the head and neck area in EuropeVan Dijk, B. A. C. / Gatta, G. / Capocaccia, R. / Pierannunzio, D. / Strojan, P. / Licitra, L. et al. | 2012
- 797
-
Reduction of population-based cancer survival estimates by trace back of death certificate notifications: An empirical illustrationHolleczek, B. / Brenner, H. et al. | 2012
- 805
-
Examining five- and ten-year survival in older women with breast cancer using cancer-specific geriatric assessmentClough-Gorr, K. M. / Thwin, S. S. / Stuck, A. E. / Silliman, R. A. et al. | 2012
- 813
-
Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III studyBraendengen, M. / Tveit, K. M. / Hjermstad, M. J. / Johansson, H. / Berglund, A. / Brandberg, Y. / Glimelius, B. et al. | 2012
- 820
-
A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancerFerrarotto, R. / Machado, K. / Mak, M. P. / Shah, N. / Takahashi, T. K. / Costa, F. P. / Overman, M. J. / Kopetz, S. / Hoff, P. M. et al. | 2012
- 827
-
The functional significance of miR-1 and miR-133a in renal cell carcinomaKawakami, K. / Enokida, H. / Chiyomaru, T. / Tatarano, S. / Yoshino, H. / Kagara, I. / Gotanda, T. / Tachiwada, T. / Nishiyama, K. / Nohata, N. et al. | 2012
- 837
-
Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modellingOhri, N. / Dicker, A. P. / Trabulsi, E. J. / Showalter, T. N. et al. | 2012
- 845
-
Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia IIIRapiti, E. / Usel, M. / Neyroud-Caspar, I. / Merglen, A. / Verkooijen, H. M. / Vlastos, A. T. / Pache, J. C. / Kumar, N. / Bouchardy, C. et al. | 2012
- 853
-
Body mass index does not influence post-treatment survival in early stage endometrial cancer: Results from the MRC ASTEC trialCrosbie, E. J. / Roberts, C. / Qian, W. / Swart, A. M. / Kitchener, H. C. / Renehan, A. G. et al. | 2012
- 865
-
Association of galectin-3 expression with melanoma progression and prognosisBrown, E. R. / Doig, T. / Anderson, N. / Brenn, T. / Doherty, V. / Xu, Y. / Bartlett, J. M. S. / Smyth, J. F. / Melton, D. W. et al. | 2012
- 875
-
Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled studySharma, A. / Rath, G. K. / Chaudhary, S. P. / Thakar, A. / Mohanti, B. K. / Bahadur, S. et al. | 2012
- 882
-
To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic areaJin, Y. / Cai, X. Y. / Cai, Y. C. / Cao, Y. / Xia, Q. / Tan, Y. T. / Jiang, W. Q. / Shi, Y. X. et al. | 2012
- 889
-
Chronic Lymphocytic Leukaemia in the Netherlands: Trends in incidence, treatment and survival, 1989-2008van den Broek, E. C. / Kater, A. P. / van de Schans, S. A. M. / Karim-Kos, H. E. / Janssen-Heijnen, M. L. G. / Peters, W. G. / Nooijen, P. T. G. A. / Coebergh, J. W. W. / Posthuma, E. F. M. et al. | 2012
- 896
-
Appropriate end-points for right results in the age of antiangiogenic agents: Future options for phase II trials in patients with recurrent glioblastomaOn behalf of European Organisation for Research and Treatment of Cancer Brain Tumour Group / Brandes, A. A. / Franceschi, E. / Gorlia, T. / Wick, W. / Jacobs, A. H. / Baumert, B. G. / van den Bent, M. / Weller, M. / Stupp, R. et al. | 2012
- 904
-
The CareGiver Oncology Quality of Life questionnaire (CarGOQoL): Development and validation of an instrument to measure the quality of life of the caregivers of patients with cancerMinaya, P. / Baumstarck, K. / Berbis, J. / Goncalves, A. / Barlesi, F. / Michel, G. / Salas, S. / Chinot, O. / Grob, J. J. / Seitz, J. F. et al. | 2012
- 912
-
Physicians' preferences for prescribing oral and intravenous anticancer drugs: A Discrete Choice ExperimentBenjamin, L. / Cotte, F. E. / Philippe, C. / Mercier, F. / Bachelot, T. / Vidal-Trecan, G. et al. | 2012
- 921
-
Has there been progress in cancer care in Croatia? Assessing outcomes in a partially complete mortality follow-up settingZnaor, A. / Brenner, H. / Holleczek, B. / Gondos, A. et al. | 2012
- 929
-
BORIS in human cancers - A reviewMartin-Kleiner, I. et al. | 2012
- 936
-
ZSTK474, a specific phosphatidylinositol 3-kinase inhibitor, induces G1 arrest of the cell cycle in vivoDan, S. / Okamura, M. / Mukai, Y. / Yoshimi, H. / Inoue, Y. / Hanyu, A. / Sakaue-Sawano, A. / Imamura, T. / Miyawaki, A. / Yamori, T. et al. | 2012
- 944
-
Stop and go strategy for opioid switching requires flexibilityMercadante, S. et al. | 2012
- 946
-
Reply to Professor Mercadante: Stop and go strategy for opioid switching requires flexibilityMoksnes, K. et al. | 2012
- 949
-
Rare thoracic cancers, including peritoneum mesotheliomaSiesling, S. / Zwan, J. M. v. d. / Izarzugaza, I. / Jaal, J. / Treasure, T. / Foschi, R. / Ricardi, U. / Groen, H. / Tavilla, A. / Ardanaz, E. et al. | 2012
- 961
-
ALK translocation and crizotinib in non-small cell lung cancer: An evolving paradigm in oncology drug developmentScagliotti, G. / Stahel, R. A. / Rosell, R. / Thatcher, N. / Soria, J. C. et al. | 2012
- 974
-
Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort studyFeldt, S. / Schussel, K. / Quinzler, R. / Franzmann, A. / Czeche, S. / Ludwig, W. D. / Schulz, M. et al. | 2012
- 982
-
Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patientsBhoo-Pathy, N. / Yip, C. H. / Hartman, M. / Saxena, N. / Taib, N. A. / Ho, G. F. / Looi, L. M. / Bulgiba, A. M. / Graaf, Y. v. d. / Verkooijen, H. M. et al. | 2012
- 990
-
Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinomaBorbath, I. / Verbrugghe, L. / Lai, R. / Gigot, J. F. / Humblet, Y. / Piessevaux, H. / Sempoux, C. et al. | 2012
- 997
-
A phase II study of RO4929097 in metastatic colorectal cancerStrosberg, J. R. / Yeatman, T. / Weber, J. / Coppola, D. / Schell, M. J. / Han, G. / Almhanna, K. / Kim, R. / Valone, T. / Jump, H. et al. | 2012
- 1004
-
Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009Dikken, J. L. / Dassen, A. E. / Lemmens, V. E. P. / Putter, H. / Krijnen, P. / van der Geest, L. / Bosscha, K. / Verheij, M. / van de Velde, C. J. H. / Wouters, M. W. J. M. et al. | 2012
- 1014
-
Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infectionFu, X. / Wan, S. / Hann, H. W. / Myers, R. E. / Hann, R. S. / Au, J. / Chen, B. / Xing, J. / Yang, H. et al. | 2012
- 1023
-
Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinomaSeidel, C. / Busch, J. / Weikert, S. / Steffens, S. / Fenner, M. / Ganser, A. / Grunwald, V. et al. | 2012
- 1031
-
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinomaKeizman, D. / Ish-Shalom, M. / Pili, R. / Hammers, H. / Eisenberger, M. A. / Sinibaldi, V. / Boursi, B. / Maimon, N. / Gottfried, M. / Hayat, H. et al. | 2012
- 1038
-
Evaluation of treatment options for patients with advanced renal cell carcinoma: Assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodologyGore, M. E. / Bellmunt, J. / Eisen, T. / Escudier, B. / Mickisch, G. / Patard, J. / Porta, C. / Ravaud, A. / Schmidinger, M. / Schoffski, P. et al. | 2012
- 1048
-
Development of clinical trial protocols involving advanced radiation therapy techniques: The European Organisation for Research and Treatment of Cancer Radiation Oncology Group approachFairchild, A. / Bar-Deroma, R. / Collette, L. / Haustermans, K. / Hurkmans, C. / Lacombe, D. / Maingon, P. / Poortmans, P. / Tomsej, M. / Weber, D. C. et al. | 2012
- 1055
-
Online information as a decision making aid for cancer patients: Recommendations from the Eurocancercoms projectMaddock, C. / Camporesi, S. / Lewis, I. / Ahmad, K. / Sullivan, R. et al. | 2012
- 1060
-
The contribution of chest CT-scan at diagnosis in children with unilateral Wilms' tumour. Results of the SIOP 2001 studySmets, A. M. J. B. / Tinteren, H. v. / Bergeron, C. / Camargo, B. D. / Graf, N. / Pritchard-Jones, K. / Kraker, J. d. et al. | 2012
- 1066
-
Survivors of childhood cancer lost to follow-up can be re-engaged into active long-term follow-up by a postal health questionnaire interventionEdgar, A. B. / Borthwick, S. / Duffin, K. / Marciniak-Stepak, P. / Wallace, W. H. B. et al. | 2012
- 1074
-
Improving cachectic symptoms and immune strength of tumour-bearing mice in chemotherapy by a combination of Scutellaria baicalensis and Qing-Shu-Yi-Qi-TangWang, H. / Chan, Y. L. / Li, T. L. / Wu, C. J. et al. | 2012
- 1085
-
Inhibition of pro-inflammatory cytokines in tumour associated macrophages is a potential anti-cancer mechanism of carboxyamidotriazoleJu, R. / Wu, D. / Guo, L. / Li, J. / Ye, C. / Zhang, D. et al. | 2012
- 1096
-
Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independentHurwitz, J. L. / Stasik, I. / Kerr, E. M. / Holohan, C. / Redmond, K. M. / McLaughlin, K. M. / Busacca, S. / Barbone, D. / Broaddus, V. C. / Gray, S. G. et al. | 2012
- 1108
-
Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinomaKrol, L. C. / Methorst, N. / Knol, A. J. / Prinsen, C. / Boers, J. E. et al. | 2012
- 1116
-
Burden of extragonadal germ cell tumours in Europe and the United StatesStang, A. / Trabert, B. / Wentzensen, N. / Cook, M. B. / Rusner, C. / Oosterhuis, J. W. / McGlynn, K. A. et al. | 2012
- 1119
-
Spatial variation in stage distribution in colorectal cancer in the NetherlandsElferink, M. A. G. / Pukkala, E. / Klaase, J. M. / Siesling, S. et al. | 2012
- 1126
-
Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: Results from a large treatment observational cohort studyKabbinavar, F. F. / Flynn, P. J. / Kozloff, M. / Ashby, M. A. / Sing, A. / Barr, C. E. / Grothey, A. et al. | 2012
- 1133
-
Quality indicators for testicular cancer: A population-based studyVlayen, J. / Vrijens, F. / Devriese, S. / Beirens, K. / Van Eycken, E. / Stordeur, S. et al. | 2012
- 1141
-
Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimenEdeline, J. / Loriot, Y. / Culine, S. / Massard, C. / Albiges, L. / Blesius, A. / Escudier, B. / Fizazi, K. et al. | 2012
- 1147
-
Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trialObermair, A. / Janda, M. / Baker, J. / Kondalsamy-Chennakesavan, S. / Brand, A. / Hogg, R. / Jobling, T. W. / Land, R. / Manolitsas, T. / Nascimento, M. et al. | 2012
- 1154
-
Previous extensive sun exposure and subsequent vitamin D production in patients with basal cell carcinoma of the skin, has no protective effect on internal cancersLindelof, B. / Krynitz, B. / Ayoubi, S. / Martschin, C. / Wiegleb-Edstrom, D. / Wiklund, K. et al. | 2012
- 1159
-
Adrenal function in adult long-term survivors of nephroblastoma and neuroblastomavan Waas, M. / Neggers, S. J. C. M. M. / van Eck, J. P. / van Noesel, M. M. / van der Lely, A. J. / de Jong, F. H. / Pieters, R. / van den Heuvel-Eibrink, M. M. et al. | 2012
- 1167
-
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in EuropeThe RARECARE WG / Mallone, S. / De Vries, E. / Guzzo, M. / Midena, E. / Verne, J. / Coebergh, J. W. / Marcos-Gragera, R. / Ardanaz, E. / Martinez, R. et al. | 2012
- 1176
-
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trialsGorlia, T. / Stupp, R. / Brandes, A. A. / Rampling, R. R. / Fumoleau, P. / Dittrich, C. / Campone, M. M. / Twelves, C. C. / Raymond, E. / Hegi, M. E. et al. | 2012
- 1185
-
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: A report from the INRG projectAngelini, P. / London, W. B. / Cohn, S. L. / Pearson, A. D. J. / Matthay, K. K. / Monclair, T. / Ambros, P. F. / Shimada, H. / Leuschner, I. / Peuchmaur, M. et al. | 2012
- 1192
-
Predictors of prescription errors involving anticancer chemotherapy agentsRanchon, F. / Moch, C. / You, B. / Salles, G. / Schwiertz, V. / Vantard, N. / Franchon, E. / Dussart, C. / Henin, E. / Colomban, O. et al. | 2012
- 1200
-
Do discordant cancers share familial susceptibility?Hemminki, K. / Sundquist, J. / Brandt, A. et al. | 2012
- 1208
-
Adenoviral vector expressing short hairpin RNA targeting Wnt2B has an effective antitumour activity against Wnt2B2-overexpressing tumoursLiu, D. / Kadota, K. / Ueno, M. / Nakashima, N. / Yokomise, H. / Huang, C. l. et al. | 2012
- 1219
-
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour?Turato, C. / Buendia, M. A. / Fabre, M. / Redon, M. J. / Branchereau, S. / Quarta, S. / Ruvoletto, M. / Perilongo, G. / Grotzer, M. A. / Gatta, A. et al. | 2012
- 1227
-
Yes-associated protein promotes tumour development in luminal epithelial derived breast cancerWang, X. / Su, L. / Ou, Q. et al. | 2012
- 1235
-
The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancerHong, S. P. / Min, B. S. / Kim, T. I. / Cheon, J. H. / Kim, N. K. / Kim, H. / Kim, W. H. et al. | 2012
- 1244
-
Relationship between ^1^8F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesotheliomaKaira, K. / Serizawa, M. / Koh, Y. / Takahashi, T. / Hanaoka, H. / Oriuchi, N. / Endo, M. / Kondo, H. / Nakajima, T. / Yamamoto, N. et al. | 2012
- 1257
-
Training breast care nurses throughout Europe: The EONS postbasic curriculum for breast cancer nursingEicher, M. / Kadmon, I. / Claassen, S. / Marquard, S. / Pennery, E. / Wengstrom, Y. / Fenlon, D. et al. | 2012
- 1263
-
Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: A prospective long-term follow-up studyden Heijer, M. / Seynaeve, C. / Timman, R. / Duivenvoorden, H. J. / Vanheusden, K. / Tilanus-Linthorst, M. / Menke-Pluijmers, M. B. E. / Tibben, A. et al. | 2012
- 1269
-
Type 2 diabetes mellitus and colorectal cancer: Meta-analysis on sex-specific differencesKramer, H. U. / Schottker, B. / Raum, E. / Brenner, H. et al. | 2012
- 1283
-
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancerMaraveyas, A. / Waters, J. / Roy, R. / Fyfe, D. / Propper, D. / Lofts, F. / Sgouros, J. / Gardiner, E. / Wedgwood, K. / Ettelaie, C. et al. | 2012
- 1293
-
Impact of age on choice of chemotherapy and outcome in advanced colorectal cancerKhattak, M. A. / Townsend, A. R. / Beeke, C. / Karapetis, C. S. / Luke, C. / Padbury, R. / Maddern, G. / Roder, D. / Price, T. J. et al. | 2012
- 1299
-
Lung cancer in never smokers - A reviewCouraud, S. / Zalcman, G. / Milleron, B. / Morin, F. / Souquet, P. J. et al. | 2012
- 1312
-
Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancerHeck, M. M. / Kron, M. / Gschwend, J. E. / Herkommer, K. et al. | 2012
- 1318
-
Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapyVan der Kwast, T. / Al Daoud, N. / Collette, L. / Sykes, J. / Thoms, J. / Milosevic, M. / Bristow, R. G. / Van Tienhoven, G. / Warde, P. / Mirimanoff, R. O. et al. | 2012
- 1326
-
Long term renal toxicity of ifosfamide in adult patients - 5year dataFarry, J. K. / Flombaum, C. D. / Latcha, S. et al. | 2012
- 1332
-
Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancerTorfs, S. / Cadron, I. / Amant, F. / Leunen, K. / Berteloot, P. / Vergote, I. et al. | 2012
- 1341
-
Population-based evidence of increased survival in human papillomavirus-related head and neck cancerNygard, M. / Aagnes, B. / Bray, F. / Moller, B. / Mork, J. et al. | 2012
- 1347
-
Results of a phase II study of sirolimus and cyclophosphamide in patients with advanced sarcomaSchuetze, S. M. / Zhao, L. / Chugh, R. / Thomas, D. G. / Lucas, D. R. / Metko, G. / Zalupski, M. M. / Baker, L. H. et al. | 2012
- 1354
-
Prognostic value of circulating VEGFR2^+ bone marrow-derived progenitor cells in patients with advanced cancerMassard, C. / Borget, I. / Deley, M. C. L. / Taylor, M. / Gomez-Roca, C. / Soria, J. C. / Farace, F. et al. | 2012
- 1363
-
Treatment-related mortality in children with acute myeloid leukaemia in Central America: Incidence, timing and predictorsGupta, S. / Bonilla, M. / Valverde, P. / Fu, L. / Howard, S. C. / Ribeiro, R. C. / Sung, L. et al. | 2012
- 1370
-
Synovial sarcoma in children and adolescents: A critical reappraisal of staging investigations in relation to the rate of metastatic involvement at diagnosisFerrari, A. / De Salvo, G. L. / Oberlin, O. / Casanova, M. / De Paoli, A. / Rey, A. / Minard, V. / Orbach, D. / Carli, M. / Brennan, B. et al. | 2012
- 1376
-
Risk adapted chemotherapy for localised Ewing's sarcoma of bone: The French EW93 studyGaspar, N. / Rey, A. / Berard, P. M. / Michon, J. / Gentet, J. C. / Tabone, M. D. / Roche, H. / Defachelles, A. S. / Lejars, O. / Plouvier, E. et al. | 2012
- 1386
-
Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect sizeMauer, M. / Collette, L. / Bogaerts, J. et al. | 2012
- 1392
-
Cancer guideline development in Europe: A survey among ECCO membersSchrijvers, D. / Turco, M. R. D. / Maddock, C. / Marotti, L. / Hemelryck, F. V. et al. | 2012
- 1401
-
p63 transcriptionally regulates BNC1, a Pol I and Pol II transcription factor that regulates ribosomal biogenesis and epithelial differentiationBoldrup, L. / Coates, P. J. / Laurell, G. / Nylander, K. et al. | 2012
- 1407
-
Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodentsUshio, S. / Egashira, N. / Sada, H. / Kawashiri, T. / Shirahama, M. / Masuguchi, K. / Oishi, R. et al. | 2012
- 1414
-
Reply letter to: Salvage radiotherapy: A plea for dose-escalation with intensity modulated radiotherapyOhri, N. / Dicker, A. P. / Showalter, T. N. et al. | 2012
- 1415
-
Salvage radiotherapy: A plea for dose-escalation with intensity-modulated radiotherapyOst, P. / Cozzarini, C. / Bossi, A. / Meerleer, G. D. et al. | 2012
- 1417
-
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002Faivre, J. / Trama, A. / De Angelis, R. / Elferink, M. / Siesling, S. / Audisio, R. / Bosset, J. F. / Cervantes, A. / Lepage, C. et al. | 2012
- 1425
-
Embryonal cancers in EuropeGatta, G. / Ferrari, A. / Stiller, C. A. / Pastore, G. / Bisogno, G. / Trama, A. / Capocaccia, R. et al. | 2012
- 1434
-
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placeboVickers, M. M. / Powell, E. D. / Asmis, T. R. / Jonker, D. J. / Hilton, J. F. / O'Callaghan, C. J. / Tu, D. / Parulekar, W. / Moore, M. J. et al. | 2012
- 1443
-
Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: Results of a randomised multicentre trialKornmann, M. / Hebart, H. / Danenberg, K. / Goeb, R. / Staib, L. / Kron, M. / Henne-Bruns, D. / Danenberg, P. / Link, K. H. et al. | 2012
- 1452
-
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trialCheng, A. L. / Guan, Z. / Chen, Z. / Tsao, C. J. / Qin, S. / Kim, J. S. / Yang, T. S. / Tak, W. Y. / Pan, H. / Yu, S. et al. | 2012
- 1466
-
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trialsBokemeyer, C. / Cutsem, E. V. / Rougier, P. / Ciardiello, F. / Heeger, S. / Schlichting, M. / Celik, I. / Kohne, C. H. et al. | 2012
- 1476
-
Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: Cell type is the most useful prognostic factorBamias, A. / Sotiropoulou, M. / Zagouri, F. / Trachana, P. / Sakellariou, K. / Kostouros, E. / Kakoyianni, K. / Rodolakis, A. / Vlahos, G. / Haidopoulos, D. et al. | 2012
- 1484
-
Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: A Taiwanese Gynecologic Oncology Group studyWang, K. L. / Chang, T. C. / Jung, S. M. / Chen, C. H. / Cheng, Y. M. / Wu, H. H. / Liou, W. S. / Hsu, S. T. / Ou, Y. C. / Yeh, L. S. et al. | 2012
- 1495
-
Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunineKrajewski, K. M. / Fougeray, R. / Bellmunt, J. / Pons, F. / Schutz, F. A. B. / Rosenberg, J. E. / Salhi, Y. / Choueiri, T. K. et al. | 2012
- 1503
-
Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomySun, M. / Abdollah, F. / Bianchi, M. / Trinh, Q. D. / Shariat, S. F. / Jeldres, C. / Tian, Z. / Hansen, J. / Briganti, A. / Graefen, M. et al. | 2012
- 1512
-
Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: Analysis of response and progression-free survival in the RECORD-1 studyOudard, S. / Thiam, R. / Fournier, L. S. / Medioni, J. / Lamuraglia, M. / Scotte, F. / Fabre, E. / Kim, D. / Kpamegan, E. / Panneerselvam, A. et al. | 2012
- 1519
-
Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcomeDabydeen, D. A. / Jagannathan, J. P. / Ramaiya, N. / Krajewski, K. / Schutz, F. A. B. / Cho, D. C. / Pedrosa, I. / Choueiri, T. K. et al. | 2012
- 1525
-
Association between 11 genetic polymorphisms in folate-metabolising genes and head and neck cancer riskGalbiatti, A. L. S. / Silva, L. M. R. B. d. / Ruiz-Cintra, M. T. / Raposo, L. S. / Maniglia, J. V. / Pavarino, E. C. / Goloni-Bertollo, E. M. et al. | 2012
- 1532
-
Epidemiology of glial and non-glial brain tumours in EuropeCrocetti, E. / Trama, A. / Stiller, C. / Caldarella, A. / Soffietti, R. / Jaal, J. / Weber, D. C. / Ricardi, U. / Slowinski, J. / Brandes, A. et al. | 2012
- 1543
-
Prognostic stratification for children with hepatoblastoma: The SIOPEL experienceMaibach, R. / Roebuck, D. / Brugieres, L. / Capra, M. / Brock, P. / Dall'Igna, P. / Otte, J. B. / De Camargo, B. / Zsiros, J. / Zimmermann, A. et al. | 2012
- 1550
-
SMAD3 is essential for transforming growth factor-@b1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytesKocic, J. / Bugarski, D. / Santibanez, J. F. et al. | 2012
- 1558
-
CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cellsReinartz, S. / Failer, S. / Schuell, T. / Wagner, U. et al. | 2012
- 1570
-
p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapyAttias-Geva, Z. / Bentov, I. / Kidron, D. / Amichay, K. / Sarfstein, R. / Fishman, A. / Bruchim, I. / Werner, H. et al. | 2012
- 1581
-
Effects of the combination of RAD001 and docetaxel on breast cancer stem cellsZhang, X. / Zhang, S. / Liu, Y. / Liu, J. / Ma, Y. / Zhu, Y. / Zhang, J. et al. | 2012
- 1593
-
Effect of cigarette smoking on quality of life in small cell lung cancer patientsChen, J. / Qi, Y. / Wampfler, J.A. / Jatoi, A. / Garces, Y.I. / Busta, A.J. / Mandrekar, S.J. / Yang, P. et al. | 2012
- 1602
-
Reference values of oesophago-gastric symptoms (EORTC QLQ-OG25) in a population-based settingvan der Schaaf, M. / Derogar, M. / Lagergren, P. et al. | 2012
- 1608
-
Malignant pancreatic neuroendocrine tumour: Lymph node ratio and Ki67 are predictors of recurrence after curative resectionsBoninsegna, L. / Panzuto, F. / Partelli, S. / Capelli, P. / Fave, G.D. / Bettini, R. / Pederzoli, P. / Scarpa, A. / Falconi, M. et al. | 2012
- 1616
-
Treatment strategies for patients with stage IV rectal cancer: A report from the Swedish Rectal Cancer RegistryKhani, M.H. / Pahlman, L. / Smedh, K. et al. | 2012
- 1624
-
Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the NetherlandsDikken, J.L. / Lemmens, V.E. / Wouters, M.W.J.M. / Wijnhoven, B.P. / Siersema, P.D. / Nieuwenhuijzen, G.A. / van Sandick, J.W. / Cats, A. / Verheij, M. / Coebergh, J.W. et al. | 2012
- 1633
-
Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening studyCarozzi, F. / Ronco, G. / Gillio-Tos, A. / De Marco, L. / Del Mistro, A. / Girlando, S. / Franceschi, S. / Plummer, M. / Vaccarella, S. et al. | 2012
- 1638
-
Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm dataNout, R.A. / Putter, H. / Jurgenliemk-Schulz, I.M. / Jobsen, J.J. / Lutgens, L.C.H.W. / van der Steen-Banasik, E.M. / Mens, J.W.M. / Slot, A. / Kroese, M.C.S. / Nijman, H.W. et al. | 2012
- 1649
-
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal massesVan Gorp, T. / Veldman, J. / Van Calster, B. / Cadron, I. / Leunen, K. / Amant, F. / Timmerman, D. / Vergote, I. et al. | 2012
- 1657
-
Does baseline total testosterone improve the yielding of prostate cancer screening?Botelho, F. / Pina, F. / Figueiredo, L. / Cruz, F. / Lunet, N. et al. | 2012
- 1664
-
Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?Kim, M.M. / Hoffman, K.E. / Levy, L.B. / Frank, S.J. / Pugh, T.J. / Choi, S. / Nguyen, Q.N. / McGuire, S.E. / Lee, A.K. / Kuban, D.A. et al. | 2012
- 1672
-
Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe SwedenThorstenson, A. / Bratt, O. / Akre, O. / Hellborg, H. / Holmberg, L. / Lambe, M. / Bill-Axelson, A. / Stattin, P. / Adolfsson, J. et al. | 2012
- 1682
-
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancerXu, J. / Muller, S. / Nannapaneni, S. / Pan, L. / Wang, Y. / Peng, X. / Wang, D. / Tighiouart, M. / Chen, Z. / Saba, N.F. et al. | 2012
- 1692
-
Sham-controlled, randomised, feasibility trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinomaMeng, Z. / Garcia, M.K. / Hu, C. / Chiang, J. / Chambers, M. / Rosenthal, D.I. / Peng, H. / Wu, C. / Zhao, Q. / Zhao, G. et al. | 2012
- 1700
-
Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - An Anglo-French collaborative reportShankar, A. / Hall, G.W. / Gorde-Grosjean, S. / Hasenclever, D. / Leblanc, T. / Hayward, J. / Lambilliotte, A. / Daw, S. / Perel, Y. / McCarthy, K. et al. | 2012
- 1707
-
Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?Iehara, T. / Hiyama, E. / Tajiri, T. / Yoneda, A. / Hamazaki, M. / Fukuzawa, M. / Hosoi, H. / Sugimoto, T. / Sawada, T. et al. | 2012
- 1713
-
Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30Cocks, K. / King, M.T. / Velikova, G. / de Castro, G. / St-James, M.M. / Fayers, P.M. / Brown, J.M. et al. | 2012
- 1722
-
Case-control study of shift-work and breast cancer risk in Danish nurses: Impact of shift systemsHansen, J. / Stevens, R.G. et al. | 2012
- 1730
-
Glutamine inhibits platelet-activating factor-mediated pulmonary tumour metastasisKim, H.-A. / Kim, K.-J. / Yoon, S.Y. / Lee, H.-K. / Im, S.-Y. et al. | 2012
- 1739
-
Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation statusEisenhofer, G. / Lenders, J.W.M. / Siegert, G. / Bornstein, S.R. / Friberg, P. / Milosevic, D. / Mannelli, M. / Linehan, W.M. / Adams, K. / Timmers, H.J. et al. | 2012
- 1751
-
Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancerTanis, E. / van de Velde, C.J.H. / Bartelink, H. / van de Vijver, M.J. / Putter, H. / van der Hage, J.A. et al. | 2012
- 1757
-
Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases - A systematic reviewChua, T.C. / Saxena, A. / Liauw, W. / Chu, F. / Morris, D.L. et al. | 2012
- 1766
-
Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?Walter, T. / Chardon, L. / Chopin-laly, X. / Raverot, V. / Caffin, A.-G. / Chayvialle, J.-A. / Scoazec, J.-Y. / Lombard-Bohas, C. et al. | 2012
- 1774
-
Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancerRodriguez, J. / Zarate, R. / Bandres, E. / Boni, V. / Hernandez, A. / Sola, J.J. / Honorato, B. / Bitarte, N. / Garcia-Foncillas, J. et al. | 2012
- 1781
-
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?Bonnetain, F. / Bosset, J.F. / Gerard, J.P. / Calais, G. / Conroy, T. / Mineur, L. / Bouche, O. / Maingon, P. / Chapet, O. / Radosevic-Jelic, L. et al. | 2012
- 1791
-
Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: A systematic review and meta-analysisWu, Z. / Ouyang, J. / He, Z. / Zhang, S. et al. | 2012
- 1799
-
Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: Characteristics of the respondersGok, M. / Heideman, D.A.M. / van Kemenade, F.J. / de Vries, A.L.M. / Berkhof, J. / Rozendaal, L. / Belien, J.A.M. / Overbeek, L. / Babovic, M. / Snijders, P.J.F. et al. | 2012
- 1809
-
Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohortvan Vugt, H.A. / Kranse, R. / Steyerberg, E.W. / van der Poel, H.G. / Busstra, M. / Kil, P. / Oomens, E.H. / de Jong, I.J. / Bangma, C.H. / Roobol, M.J. et al. | 2012
- 1816
-
Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal functionMorales-Barrera, R. / Bellmunt, J. / Suarez, C. / Valverde, C. / Guix, M. / Serrano, C. / Gallen, M. / Carles, J. et al. | 2012
- 1822
-
Modest improvement in 20 years of kidney cancer care in the Netherlandsvan de Schans, S.A.M. / Aben, K.K.H. / Mulders, P.F.A. / Haanen, J.B.A.G. / van Herpen, C. / Verhoeven, R.H.A. / Karim-Kos, H.E. / Oosterwijk, E. / Kiemeney, L.A.L.M. et al. | 2012
- 1831
-
Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cellsAndrae, N. / Kirches, E. / Hartig, R. / Haase, D. / Keilhoff, G. / Kalinski, T. / Mawrin, C. et al. | 2012
- 1842
-
Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutationsSchoenewolf, N.L. / Bull, C. / Belloni, B. / Holzmann, D. / Tonolla, S. / Lang, R. / Mihic-Probst, D. / Andres, C. / Dummer, R. et al. | 2012
- 1853
-
Potential biomarkers for hepatoblastoma: Results from the SIOPEL-3 studyPurcell, R. / Childs, M. / Maibach, R. / Miles, C. / Turner, C. / Zimmermann, A. / Czauderna, P. / Sullivan, M. et al. | 2012
- 1860
-
Allergy-associated symptoms in relation to childhood non-Hodgkin's as contrasted to Hodgkin's lymphomas: A case-control study in Greece and meta-analysisDikalioti, S.K. / Chang, E.T. / Dessypris, N. / Papadopoulou, C. / Skenderis, N. / Pourtsidis, A. / Moschovi, M. / Polychronopoulou, S. / Athanasiadou-Piperopoulou, F. / Sidi, V. et al. | 2012
- 1867
-
Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumoursMouravieva, A.A.K. / Geurts-Giele, I.R.R. / de Krijger, R.R. / van Noesel, M.M. / van de Ven, C.P. / van den Ouweland, A.M.W. / Kromosoeto, J.N.R. / Dinjens, W.N.M. / Dubbink, H.J. / Smits, R. et al. | 2012
- 1875
-
Risk of haemorrhagic and ischaemic stroke in patients with cancer: A nationwide follow-up study from SwedenZoller, B. / Ji, J. / Sundquist, J. / Sundquist, K. et al. | 2012
- 1884
-
The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemiaZhao, Z.-G. / Xu, W. / Sun, L. / Li, W.-M. / Li, Q.-B. / Zou, P. et al. | 2012
- 1896
-
Fluorescence lifetime imaging of E-combretastatin uptake and distribution in live mammalian cellsBisby, R.H. / Botchway, S.W. / Hadfield, J.A. / McGown, A.T. / Parker, A.W. / Scherer, K.M. et al. | 2012
- 1904
-
MicroRNA-610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator-stimulated phosphoproteinWang, J. / Zhang, J. / Wu, J. / Luo, D. / Su, K. / Shi, W. / Liu, J. / Tian, Y. / Wei, L. et al. | 2012
- 1914
-
High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasionKim, H.-J. / Jeon, H.-K. / Cho, Y.J. / Park, Y.A. / Choi, J.-J. / Do, I.-G. / Song, S.Y. / Lee, Y.-Y. / Choi, C.H. / Kim, T.-J. et al. | 2012
- 1923
-
Carcinoma of endocrine organs: Results of the RARECARE projectvan der Zwan, J.M. / Mallone, S. / van Dijk, B. / Bielska-Lasota, M. / Otter, R. / Foschi, R. / Baudin, E. / Links, T.P. / The RARECARE WG et al. | 2012
- 1932
-
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancerBartsch, R. / Bago-Horvath, Z. / Berghoff, A. / DeVries, C. / Pluschnig, U. / Dubsky, P. / Rudas, M. / Mader, R.M. / Rottenfusser, A. / Fitzal, F. et al. | 2012
- 1939
-
Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed?Huiart, L. / Bouhnik, A.-D. / Rey, D. / Tarpin, C. / Cluze, C. / Bendiane, M.K. / Viens, P. / Giorgi, R. et al. | 2012
- 1947
-
Mastectomy trends for early-stage breast cancer: A report from the EUSOMA multi-institutional European databaseGarcia-Etienne, C.A. / Tomatis, M. / Heil, J. / Friedrichs, K. / Kreienberg, R. / Denk, A. / Kiechle, M. / Lorenz-Salehi, F. / Kimmig, R. / Emons, G. et al. | 2012
- 1957
-
Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer ConsortiumCote, M.L. / Liu, M. / Bonassi, S. / Neri, M. / Schwartz, A.G. / Christiani, D.C. / Spitz, M.R. / Muscat, J.E. / Rennert, G. / Aben, K.K. et al. | 2012
- 1969
-
Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, CanadaHedden, L. / Kennecke, H. / Villa, D. / Johnston, K. / Speers, C. / Kovacic, L. / Renouf, D.J. / Peacock, S. et al. | 2012
- 1977
-
Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinomaChen, L. / Zhang, Q. / Chang, W. / Du, Y. / Zhang, H. / Cao, G. et al. | 2012
- 1988
-
SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancerKnappskog, S. / Trovik, J. / Marcickiewicz, J. / Tingulstad, S. / Staff, A.C. / p / Romundstad, P. / Hveem, K. / Vatten, L. / Salvesen, H.B. et al. | 2012
- 1997
-
Successful centralisation of patients with vulvar carcinoma: A population-based study in The Netherlandsvan den Einden, L.C.G. / Aben, K.K.H. / Massuger, L.F.A.G. / van Spronsen, D.J. / de Hullu, J.A. et al. | 2012
- 2004
-
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patientsSpeeckaert, R. / Vermaelen, K. / van Geel, N. / Autier, P. / Lambert, J. / Haspeslagh, M. / van Gele, M. / Thielemans, K. / Neyns, B. / Roche, N. et al. | 2012
- 2012
-
Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2bBrandberg, Y. / Aamdal, S. / Bastholt, L. / Hernberg, M. / Stierner, U. / von der Maase, H. / Hansson, J. et al. | 2012
- 2020
-
Local therapy is critical in localised pelvic rhabdomyosarcoma: Experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committeeReguerre, Y. / Martelli, H. / Rey, A. / Rogers, T. / Gaze, M. / Arush, M.W.B. / Devalck, C. / Oberlin, O. / Stevens, M. / Orbach, D. et al. | 2012
- 2028
-
A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastomaGerber, N.U. / von Hoff, K. / von Bueren, A.O. / Treulieb, W. / Deinlein, F. / Benesch, M. / Zwiener, I. / Soerensen, N. / Warmuth-Metz, M. / Pietsch, T. et al. | 2012
- 2037
-
Socio-economic implications of cancer survivorship: Results from the PROFILES registryMols, F. / Thong, M.S.Y. / Vissers, P. / Nijsten, T. / van de Poll-Franse, L.V. et al. | 2012
- 2043
-
Cancer risk and prevention in a globalised world: Solving the public policy mismatchSullivan, R. / Homberg, L. / Purushotham, A.D. et al. | 2012
- 2046
-
Trends of cutaneous squamous cell carcinoma in the Netherlands: Increased incidence rates, but stable relative survival and mortality 1989-2008Hollestein, L.M. / de Vries, E. / Nijsten, T. et al. | 2012
- 2054
-
Comparative evaluation of the biological properties of reducible and acid-sensitive folate prodrugs of a highly potent doxorubicin derivativeAjaj, K.A. / El-Abadla, N. / Welker, P. / Azab, S. / Zeisig, R. / Fichtner, I. / Kratz, F. et al. | 2012
- 2066
-
Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypesLiedtke, C. / Packeisen, J. / Hess, K.R. / Vogt, U. / Kiesel, L. / Kersting, C. / Korsching, E. / Brandt, B. / Buerger, H. et al. | 2012
- 2075
-
Edible oil adulterants, argemone oil and butter yellow, as aetiological factors for gall bladder cancerMishra, V. / Mishra, M. / Ansari, K.M. / Chaudhari, B.P. / Khanna, R. / Das, M. et al. | 2012
- 2086
-
Inhibition of human hepatocellular carcinoma HepG2 by phthalocyanine photosensitiser PHOTOCYANINE: ROS production, apoptosis, cell cycle arrestShao, J. / Xue, J. / Dai, Y. / Liu, H. / Chen, N. / Jia, L. / Huang, J. et al. | 2012
- 2097
-
Mammographic changes resulting from benign breast surgery impair breast cancer detection at screening mammographyvan Breest Smallenburg, V. / Duijm, L.E.M. / Voogd, A.C. / Jansen, F.H. / Louwman, M.W.J. et al. | 2012
- 2104
-
Stem cells in breast tumours: Are they ready for the clinic?Ablett, M.P. / Singh, J.K. / Clarke, R.B. et al. | 2012
- 2117
-
Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignanciesWedlake, L.J. / Silia, F. / Benton, B. / Lalji, A. / Thomas, K. / Dearnaley, D.P. / Blake, P. / Tait, D. / Khoo, V.S. / Andreyev, H.J.N. et al. | 2012
- 2125
-
Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysisLiu, Y. / Chang, C.-C.H. / Marsh, G.M. / Wu, F. et al. | 2012
- 2137
-
Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studiesChen, Y. / Wang, X. / Wang, J. / Yan, Z. / Luo, J. et al. | 2012
- 2146
-
Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?Trope, C.G. / Elstrand, M.B. / Sandstad, B. / Davidson, B. / Oksefjell, H. et al. | 2012
- 2155
-
Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trialKondalsamy-Chennakesavan, S. / Janda, M. / Gebski, V. / Baker, J. / Brand, A. / Hogg, R. / Jobling, T.W. / Land, R. / Manolitsas, T. / Nascimento, M. et al. | 2012
- 2163
-
How do lung cancer specialists follow their patients with stage III non-small cell lung cancer (NSCLC) after definitive treatment? - A short reportYumuk, P.F. / Mohammed, N. / Maat, A.P.W.M. / Fink, C. / Marchal, B. / O Brien, M.E.R. et al. | 2012
- 2166
-
Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinomaKlimowicz, A.C. / Bose, P. / Nakoneshny, S.C. / Dean, M. / Huang, L. / Chandarana, S. / Magliocco, A.M. / Matthews, T.W. / Brockton, N.T. / Dort, J.C. et al. | 2012
- 2175
-
Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: Results from a retrospective, longitudinal survey (MELODY study)Johnston, K. / Levy, A.R. / Lorigan, P. / Maio, M. / Lebbe, C. / Middleton, M. / Testori, A. / Bedane, C. / Konto, C. / Dueymes, A. et al. | 2012
- 2183
-
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysisIbarrola-Villava, M. / Hu, H.-H. / Guedj, M. / Fernandez, L.P. / Descamps, V. / Basset-Seguin, N. / Bagot, M. / Benssussan, A. / Saiag, P. / Fargnoli, M.C. et al. | 2012
- 2192
-
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modalityStupp, R. / Wong, E.T. / Kanner, A.A. / Steinberg, D. / Engelhard, H. / Heidecke, V. / Kirson, E.D. / Taillibert, S. / Liebermann, F. / Dbaly, V. et al. | 2012
- 2203
-
The EORTC QLQ-OH17: A supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patientsHjermstad, M.J. / Bergenmar, M. / Fisher, S.E. / Montel, S. / Nicolatou-Galitis, O. / Raber-Durlacher, J. / Singer, S. / Leeuw, I.V.-d. / Weis, J. / Yarom, N. et al. | 2012
- 2212
-
Cancer screening and health system resilience: Keys to protecting and bolstering preventive services during a financial crisisMartin-Moreno, J.M. / Anttila, A. / von Karsa, L. / Alfonso-Sanchez, J.L. / Gorgojo, L. et al. | 2012
- 2219
-
Clear cell sarcoma of the kidney: A reviewGooskens, S.L.M. / Furtwangler, R. / Vujanic, G.M. / Dome, J.S. / Graf, N. / van den Heuvel-Eibrink, M.M. et al. | 2012
- 2227
-
Opposite effects of microchimerism on breast and colon cancerKamper-Jorgensen, M. / Biggar, R.J. / Tjonneland, A. / Hjalgrim, H. / Kroman, N. / Rostgaard, K. / Stamper, C.L. / Olsen, A. / Andersen, A.-M.N. / Gadi, V.K. et al. | 2012
- 2236
-
Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo)Meschini, S. / Condello, M. / Lista, P. / Vincenzi, B. / Baldi, A. / Citro, G. / Arancia, G. / Spugnini, E.P. et al. | 2012
- 2244
-
CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancerKawamura, M. / Toiyama, Y. / Tanaka, K. / Saigusa, S. / Okugawa, Y. / Hiro, J. / Uchida, K. / Mohri, Y. / Inoue, Y. / Kusunoki, M. et al. | 2012
- 2252
-
Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCsSong, S. / Wang, Y. / Wang, J. / Lian, W. / Liu, S. / Zhang, Z. / Liu, F. / Wei, L. et al. | 2012
- 2260
-
The antitumour activities induced by pegylated liposomal cytochalasin D in murine modelsHuang, F.-y. / Mei, W.-l. / Li, Y.-n. / Tan, G.-h. / Dai, H.-f. / Guo, J.-l. / Wang, H. / Huang, Y.-h. / Zhao, H.-g. / Zhou, S.-l. et al. | 2012
- 2270
-
A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancerHuidobro, C. / Urdinguio, R.G. / Rodriguez, R.M. / Mangas, C. / Calvanese, V. / Martinez-Camblor, P. / Ferrero, C. / Parra-Blanco, A. / Rodrigo, L. / Obaya, A.J. et al. | 2012
- 2282
-
A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppressionYamasaki, Y. / Tazawa, H. / Hashimoto, Y. / Kojima, T. / Kuroda, S. / Yano, S. / Yoshida, R. / Uno, F. / Mizuguchi, H. / Ohtsuru, A. et al. | 2012
- 2292
-
Corrigendum to: ``Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy'' [Eur J Cancer 2012;48(9): 1318-25]Van der Kwast, T. / Daoud, N.A. / Collette, L. / Sykes, J. / Thoms, J. / Milosevic, M. / Bristow, R.G. / Van Tienhoven, G. / Warde, P. / Mirimanoff, R.-O. et al. | 2012
- 2293
-
Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: A clinical experience in 108 patients with metastatic breast cancerArnedos, M. / Scott, V. / Job, B. / De La Cruz, J. / Commo, F. / Mathieu, M.C. / Wolp-Diniz, R. / Richon, C. / Campone, M. / Bachelot, T. et al. | 2012
- 2300
-
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matchingLe Ray, I. / Dabakuyo, S. / Crehange, G. / Bardou, M. / Arnould, L. / Fraisse, J. / Fumoleau, P. / Coudert, B. / Causeret, S. / Arveux, P. et al. | 2012
- 2311
-
Clinical and radiological predictors of nipple-areola complex involvement in breast cancer patientsD Alonzo, M. / Martincich, L. / Biglia, N. / Pisacane, A. / Maggiorotto, F. / De Rosa, G. / Montemurro, F. / Kubatzki, F. / Sismondi, P. / Ponzone, R. et al. | 2012
- 2319
-
Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic-based longitudinal cohortHann, H.-W. / Fu, X. / Myers, R.E. / Hann, R.S. / Wan, S. / Kim, S.H. / Au, N. / Xing, J. / Yang, H. et al. | 2012
- 2328
-
Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: Evidence from a systematic review and meta-analysisLiu, J. / Ma, Q. / Zhang, M. / Wang, X. / Zhang, D. / Li, W. / Wang, F. / Wu, E. et al. | 2012
- 2339
-
Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancervan Baardwijk, A. / Reymen, B. / Wanders, S. / Borger, J. / Ollers, M. / Dingemans, A.-M.C. / Bootsma, G. / Geraedts, W. / Pitz, C. / Lunde, R. et al. | 2012
- 2347
-
Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma - A multicentre studySteffens, S. / Janssen, M. / Roos, F.C. / Becker, F. / Schumacher, S. / Seidel, C. / Wegener, G. / Thuroff, J.W. / Hofmann, R. / Stockle, M. et al. | 2012
- 2353
-
Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteriaHu, T. / Li, S. / Chen, Y. / Shen, J. / Li, X. / Huang, K. / Yang, R. / Wu, L. / Chen, Z. / Jia, Y. et al. | 2012
- 2361
-
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysisMonk, B.J. / Herzog, T.J. / Kaye, S.B. / Krasner, C.N. / Vermorken, J.B. / Muggia, F.M. / Pujade-Lauraine, E. / Park, Y.C. / Parekh, T.V. / Poveda, A.M. et al. | 2012
- 2369
-
Trends in sinonasal cancer in The Netherlands: More squamous cell cancer, less adenocarcinoma: A population-based study 1973-2009Kuijpens, J.L.P. / Louwman, M.W.J. / Peters, R. / Janssens, G.O.R.J. / Burdorf, A. / Coebergh, J.-W.W. et al. | 2012
- 2375
-
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2012Garbe, C. / Peris, K. / Hauschild, A. / Saiag, P. / Middleton, M. / Spatz, A. / Grob, J.-J. / Malvehy, J. / Newton-Bishop, J. / Stratigos, A. et al. | 2012
- 2391
-
Quality-of-life among head and neck cancer survivors at one year after treatment - A systematic reviewSo, W.K.W. / Chan, R.J. / Chan, D.N.S. / Hughes, B.G.M. / Chair, S.Y. / Choi, K.C. / Chan, C.W.H. et al. | 2012
- 2409
-
Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma - A report from the Societe Francaise des Cancers et leucemies de l'Enfant et de l'adolescent (SFCE)Minard-Colin, V. / Ichante, J.-L. / Nguyen, L. / Paci, A. / Orbach, D. / Bergeron, C. / Defachelles, A.-S. / Andre, N. / Corradini, N. / Schmitt, C. et al. | 2012
- 2417
-
Simultaneous inhibition of Src and Aurora kinases by SU6656 induces therapeutic synergy in human synovial sarcoma growth, invasion and angiogenesis in vivoArai, R. / Tsuda, M. / Watanabe, T. / Ose, T. / Obuse, C. / Maenaka, K. / Minami, A. / Ohba, Y. et al. | 2012
- 2431
-
Folate supplementation limits the tumourigenesis in rodent models of gliomagenesisCartron, P.-F. / Hervouet, E. / Debien, E. / Olivier, C. / Pouliquen, D. / Menanteau, J. / Loussouarn, D. / Martin, S.A. / Campone, M. / Vallette, F.M. et al. | 2012
- 2442
-
Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patientsWagner, F. / Henningsen, B. / Lederer, C. / Eichenmuller, M. / Godeke, J. / Muller-Hocker, J. / von Schweinitz, D. / Kappler, R. et al. | 2012
- 2451
-
Is there a general autoantibody signature for cancer?Ludwig, N. / Keller, A. / Leidinger, P. / Harz, C. / Backes, C. / Lenhof, H.-P. / Meese, E. et al. | 2012
- 2462
-
Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancersTian, T. / Ikeda, J.-i. / Wang, Y. / Mamat, S. / Luo, W. / Aozasa, K. / Morii, E. et al. | 2012
- 2474
-
TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acidImran, M. / Park, T.J. / Lim, I.K. et al. | 2012
- 2486
-
Increased sampling will lead to an increase in detection, but is it clinically relevant?Riber-Hansen, R. / Hastrup, N. / Clemmensen, O. / Ramsing, M. / Hamilton-Dutoit, S.J. / Steiniche, T. et al. | 2012
- 2488
-
Increased sampling will lead to an increase in detection, but is it clinically relevant?: Reply letter regarding: ``Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: A national multicentre study'' by Riber-Hansen et alvan Akkooi, A.C.J. / Cook, M.G. / Eggermont, A.M.M. et al. | 2012
- 2941
-
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - Differential treatment strategies for subtypes of early gastroesophageal cancerLutz, M.P. / Zalcberg, J.R. / Ducreux, M. / Ajani, J.A. / Allum, W. / Aust, D. / Bang, Y.-J. / Cascinu, S. / Holscher, A. / Jankowski, J. et al. | 2012
- 2954
-
A nomogram to predict individual prognosis in node-negative breast carcinomaMazouni, C. / Spyratos, F. / Romain, S. / Fina, F. / Bonnier, P. / Ouafik, L.H. / Martin, P.M. et al. | 2012
- 2962
-
Tumor characteristics and recurrence patterns in triple negative breast cancer: A comparison between younger (<65) and elderly ([unknown]65) patientsKonigsberg, R. / Pfeiler, G. / Klement, T. / Hammerschmid, N. / Brunner, A. / Zeillinger, R. / Singer, C. / Dittrich, C. et al. | 2012
- 2969
-
Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancerFaivre, J. / Dancourt, V. / Denis, B. / Dorval, E. / Piette, C. / Perrin, P. / Bidan, J.M. / Jard, C. / Jung, S. / Levillain, R. et al. | 2012
- 2977
-
Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagusStahl, M. / Lehmann, N. / Walz, M.K. / Stuschke, M. / Wilke, H. et al. | 2012
- 2983
-
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesotheliomaBlayney, J.K. / Ceresoli, G.L. / Castagneto, B. / O Brien, M.E.R. / Hasan, B. / Sylvester, R. / Rudd, R. / Steele, J. / Busacca, S. / Porta, C. et al. | 2012
- 2993
-
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)Meulenbeld, H.J. / van Werkhoven, E.D. / Coenen, J.L.L.M. / Creemers, G.J. / Loosveld, O.J.L. / de Jong, P.C. / Tije, A.J.t. / Fossa, S.D. / Polee, M. / Gerritsen, W. et al. | 2012
- 3001
-
What do British women know about cervical cancer symptoms and risk factors?Low, E.L. / Simon, A.E. / Lyons, J. / Romney-Alexander, D. / Waller, J. et al. | 2012
- 3009
-
Quality of life characteristics inpatients with cervical cancerBjelic-Radisic, V. / Jensen, P.T. / Vlasic, K.K. / Waldenstrom, A.-C. / Singer, S. / Chie, W. / Nordin, A. / Greimel, E. et al. | 2012
- 3019
-
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survivalBuglione, M. / Grisanti, S. / Almici, C. / Mangoni, M. / Polli, C. / Consoli, F. / Verardi, R. / Costa, L. / Paiar, F. / Pasinetti, N. et al. | 2012
- 3027
-
Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomasAsmane, I. / Watkin, E. / Alberti, L. / Duc, A. / Marec-Berard, P. / Ray-Coquard, I. / Cassier, P. / Decouvelaere, A.-V. / Ranchere, D. / Kurtz, J.-E. et al. | 2012
- 3036
-
A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomasLe Cesne, A. / Cresta, S. / Maki, R.G. / Blay, J.Y. / Verweij, J. / Poveda, A. / Casali, P.G. / Balana, C. / Schoffski, P. / Grosso, F. et al. | 2012
- 3045
-
Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studiesFour, S.D. / Wilgenhof, S. / Duerinck, J. / Michotte, A. / Van Binst, A. / De Ridder, M. / Neyns, B. et al. | 2012
- 3052
-
Perceptions of genetic research and testing among members of families with an increased risk of malignant melanomaBranstrom, R. / Kasparian, N.A. / Affleck, P. / Tibben, A. / Chang, Y.-m. / Azizi, E. / Baron-Epel, O. / Bergman, W. / Chan, M. / Davies, J. et al. | 2012
- 3063
-
Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trialVeal, G.J. / Nguyen, L. / Paci, A. / Riggi, M. / Amiel, M. / Valteau-Couanet, D. / Brock, P. / Ladenstein, R. / Vassal, G. et al. | 2012
- 3073
-
Symptom clusters in a population-based ambulatory cancer cohort validated using bootstrap methodsHowell, D. / Husain, A. / Seow, H. / Liu, Y. / Kustra, R. / Atzema, C. / Dudgeon, D. / Earle, C. / Sussman, J. / Barbera, L. et al. | 2012
- 3082
-
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trialsLipton, A. / Fizazi, K. / Stopeck, A.T. / Henry, D.H. / Brown, J.E. / Yardley, D.A. / Richardson, G.E. / Siena, S. / Maroto, P. / Clemens, M. et al. | 2012
- 3093
-
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growthLamers, F. / Schild, L. / Hartog, I.J.M.d. / Ebus, M.E. / Westerhout, E.M. / Ora, I. / Koster, J. / Versteeg, R. / Caron, H.N. / Molenaar, J.J. et al. | 2012
- 3104
-
miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2Chen, L. / Wang, X. / Wang, H. / Li, Y. / Yan, W. / Han, L. / Zhang, K. / Zhang, J. / Wang, Y. / Feng, Y. et al. | 2012
- 3112
-
Anandamide inhibits the Wnt/ beta -catenin signalling pathway in human breast cancer MDA MB 231 cellsLaezza, C. / D Alessandro, A. / Paladino, S. / Malfitano, A.M. / Proto, M.C. / Gazzerro, P. / Pisanti, S. / Santoro, A. / Ciaglia, E. / Bifulco, M. et al. | 2012
- 3123
-
Management of bone metastases from advanced renal cell carcinomaKhattak, M.A. / Martin, H.L. et al. | 2012
- 3126
-
Signet ring cell carcinoma as a potential confounding factor in the analysis of outcomes with colorectal mucinous adenocarcinomaRastogi, M. / Revannasiddaiah, S. / Thakur, P. / Channakeshava, S. et al. | 2012
- 3128
-
Reply letter to: Signet ring cell carcinoma as a potential confounding factor in the analysis of outcomes with colorectal mucinous adenocarcinomaMekenkamp, L.J.M. / Heesterbeek, C.J. / Punt, C.J.A. / Nagtegaal, I.D. et al. | 2012
- 3130
-
Corrigendum to ``22nd Biennial Congress of the European Association for Cancer Research Barcelona Spain, 7-10 July 2012 Proceedings Book'' [Eur. J. Cancer 48 (S5) (2012) S1-S294]| 2012
- 3131
-
Metformin decreased human melanoma cell survival but did not affect viability of normal resting PBMCDjordjic, M. / Matic, I. / Damjanovic, A. / Nikolic-Djurovic, M. / Nikolic, S. / Juranic, Z. et al. | 2012
- 3133
-
Use of Complementary and Alternative Medicine in breast cancer patients and their experiences: A cross-sectional studyTautz, E. / Momm, F. / Hasenburg, A. / Guethlin, C. et al. | 2012
- 3140
-
Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancerLang, I. / Inbar, M.J. / Kahan, Z. / Greil, R. / Beslija, S. / Stemmer, S.M. / Kaufman, B. / Zvirbule, Z. / Steger, G.G. / Messinger, D. et al. | 2012
- 3150
-
Contralateral prophylactic mastectomy in breast cancer patients with a family history: A prospective 2-years follow-up study of health related quality of life, sexuality and body imageUnukovych, D. / Sandelin, K. / Liljegren, A. / Arver, B. / Wickman, M. / Johansson, H. / Brandberg, Y. et al. | 2012
- 3157
-
High prevalence of osteoblastic bone reaction in computed tomography scans of an European Organisation for Research and Treatment of Cancer prospective randomised phase II trial in extensive stage small cell lung cancerFink, C. / Hasan, B. / Deleu, S. / Pallis, A.G. / Baas, P. / O Brien, M. et al. | 2012
- 3161
-
Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: A population-based studyOudsten, B.L.D. / Traa, M.J. / Thong, M.S.Y. / Martijn, H. / De Hingh, I.H.J.T. / Bosscha, K. / van de Poll-Franse, L.V. et al. | 2012
- 3171
-
An indirect comparison of the toxicity of sunitinib and pazopanib in metastatic clear cell renal cancerPowles, T. / Sarwar, N. / Jones, R. / Wilson, P. / Boleti, E. / Protheroe, A. et al. | 2012
- 3177
-
Urologic complication in laparoscopic radical hysterectomy: Meta-analysis of 20 studiesHwang, J.H. et al. | 2012
- 3186
-
ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinomaGrimm, M. / Krimmel, M. / Polligkeit, J. / Alexander, D. / Kluba, A.M.S. / Keutel, C. / Hoffmann, J. / Reinert, S. / Hoefert, S. et al. | 2012
- 3198
-
A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01)Ji, J.H. / Korean Cancer Study Group (KCSG) / Yun, T. / Kim, S.-B. / Kang, J.H. / Park, J.C. / Cho, I.S. / Sohn, C.H. / Heo, D.S. / Jang, J.S. et al. | 2012
- 3205
-
Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: A retrospective, longitudinal survey (MELODY study)Lebbe, C. / Lorigan, P. / Ascierto, P. / Testori, A. / Bedane, C. / Middleton, M. / van Baardewijk, M. / Konto, C. / Dueymes, A. / Maio, M. et al. | 2012
- 3215
-
Patterns of deregulation of insulin growth factor signalling pathway in paediatric and adult gastrointestinal stromal tumoursItaliano, A. / Chen, J. / Zhang, L. / Hajdu, M. / Singer, S. / DeMatteo, R.P. / Antonescu, C.R. et al. | 2012
- 3223
-
Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trialKim, S.J. / Yoon, D.H. / Kang, H.J. / Kim, J.S. / Park, S.K. / Kim, H.J. / Lee, J. / Ryoo, B.-Y. / Ko, Y.H. / Huh, J. et al. | 2012
- 3232
-
Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials?Fairchild, A. / Collette, L. / Hurkmans, C.W. / Baumert, B. / Weber, D.C. / Gulyban, A. / Poortmans, P. et al. | 2012
- 3240
-
Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01Graf, N. / van Tinteren, H. / Bergeron, C. / Pein, F. / van den Heuvel-Eibrink, M.M. / Sandstedt, B. / Schenk, J.-P. / Godzinski, J. / Oldenburger, F. / Furtwangler, R. et al. | 2012
- 3249
-
Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patientsSegers, H. / Kersseboom, R. / Alders, M. / Pieters, R. / Wagner, A. / van den Heuvel-Eibrink, M.M. et al. | 2012
- 3257
-
Incidence, survival and prevalence of myeloid malignancies in EuropeVisser, O. / Trama, A. / Maynadie, M. / Stiller, C. / Marcos-Gragera, R. / De Angelis, R. / Mallone, S. / Tereanu, C. / Allemani, C. / Ricardi, U. et al. | 2012
- 3267
-
Fruit and vegetable consumption and risk of aggressive and non-aggressive urothelial cell carcinomas in the European Prospective Investigation into Cancer and NutritionRos, M.M. / Bueno-de-Mesquita, H.B. / Kampman, E. / Buchner, F.L. / Egevad, K.K.H.A.L. / Overvad, K. / Tjonneland, A. / Roswall, N. / Clavel-Chapelon, F. / Boutron-Ruault, M.C. et al. | 2012
- 3278
-
Enhancing the anticancer effect of the histone deacetylase inhibitor by activating transglutaminaseLing, D. / Marshall, G.M. / Liu, P.Y. / Xu, N. / Nelson, C.A. / Iismaa, S.E. / Liu, T. et al. | 2012
- 3288
-
TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cellsXu, L. / Zhang, Y. / Liu, J. / Qu, J. / Hu, X. / Zhang, F. / Zheng, H. / Qu, X. / Liu, Y. et al. | 2012
- 3300
-
Specific-site methylation of tumour suppressor ANKRD11 in breast cancerLim, S.P. / Wong, N.C. / Suetani, R.J. / Ho, K. / Ng, J.L. / Neilsen, P.M. / Gill, P.G. / Kumar, R. / Callen, D.F. et al. | 2012
- 3310
-
All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/ beta -catenin pathwayLim, Y.C. / Kang, H.J. / Kim, Y.S. / Choi, E.C. et al. | 2012
- 3319
-
Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignanciesMahadevan, D. / Chiorean, E.G. / Harris, W.B. / Von Hoff, D.D. / Stejskal-Barnett, A. / Qi, W. / Anthony, S.P. / Younger, A.E. / Rensvold, D.M. / Cordova, F. et al. | 2012
- 3328
-
Use of health-care services during chemotherapy for breast cancerBaena-Canada, J.M. / Estalella-Mendoza, S. / Rosado-Varela, P. / Exposito-Alvarez, I. / Gonzalez-Guerrero, M. / Diaz-Blanco, M.C. / Cortes-Carmona, C. / Ramirez-Daffos, P. / Arriola-Arellano, E. / Rueda-Ramos, A. et al. | 2012
- 3335
-
Breast cancer among HIV infected individuals from the ONCOVIH study, in France: Therapeutic implicationsSpano, J.-P. / Lanoy, E. / Mounier, N. / Katlama, C. / Costagliola, D. / Heard, I. et al. | 2012
- 3342
-
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapyHoussami, N. / Macaskill, P. / von Minckwitz, G. / Marinovich, M.L. / Mamounas, E. et al. | 2012
- 3355
-
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancerCardoso, F. / Loibl, S. / Pagani, O. / Graziottin, A. / Panizza, P. / Martincich, L. / Gentilini, O. / Peccatori, F. / Fourquet, A. / Delaloge, S. et al. | 2012
- 3378
-
Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapySodja, E. / Knez, L. / Kern, I. / Ovcaricek, T. / Sadikov, A. / Cufer, T. et al. | 2012
- 3386
-
The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patientsLuchtenborg, M. / Jakobsen, E. / Krasnik, M. / Linklater, K.M. / Mellemgaard, A. et al. | 2012
- 3396
-
A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancerHayashi, Y. / Xiao, L. / Suzuki, A. / Blum, M.A. / Sabloff, B. / Taketa, T. / Maru, D.M. / Welsh, J. / Lin, S.H. / Weston, B. et al. | 2012
- 3405
-
Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourabl prognosis in colorectal cancerLochhead, P. / Imamura, Y. / Morikawa, T. / Kuchiba, A. / Yamauchi, M. / Liao, X. / Qian, Z.R. / Nishihara, R. / Wu, K. / Meyerhardt, J.A. et al. | 2012
- 3414
-
The value of 3.0 Tesla diffusion-weighted MRI for pelvic nodal staging in patients with early stage cervical cancerKlerkx, W.M. / Veldhuis, W.B. / Spijkerboer, A.M. / van den Bosch, M.A. / Mali, W.P. / Heintz, A.P. / Bipat, S. / Sie-Go, D.M. / van der Velden, J. / Schreuder, H.W. et al. | 2012
- 3422
-
Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapyHua, Y.-J. / Han, F. / Lu, L.-X. / Mai, H.-Q. / Guo, X. / Hong, M.-H. / Lu, T.-X. / Zhao, C. et al. | 2012
- 3429
-
The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcomaMohseny, A.B. / Cai, Y. / Kuijjer, M. / Xiao, W. / van den Akker, B. / de Andrea, C.E. / Jacobs, R. / Dijke, P.t. / Hogendoorn, P.C.W. / Cleton-Jansen, A.-M. et al. | 2012
- 3439
-
Trial design on prophylaxis and treatment of brain metastases: Lessons learned from the EORTC Brain Metastases Strategic Meeting 2012Preusser, M. / Winkler, F. / Collette, L. / Haller, S. / Marreaud, S. / Soffietti, R. / Klein, M. / Reijneveld, J.C. / Tonn, J.-C. / Baumert, B.G. et al. | 2012
- 3448
-
Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcomaFerrari, A. / De Salvo, G.L. / Dall Igna, P. / Meazza, C. / De Leonardis, F. / Manzitti, C. / de Ioris, M.A. / Casanova, M. / Carli, M. / Bisogno, G. et al. | 2012
- 3456
-
Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma - A phase II trial of the childhood liver tumour strategy group (SIOPEL)Zsiros, J. / Brugieres, L. / Brock, P. / Roebuck, D. / Maibach, R. / Child, M. / Morland, B. / Casanova, M. / Pariente, D. / Paris, C. et al. | 2012
- 3465
-
Gemcitabine causes telomere attrition by stabilizing TRF2Su, C.-H. / Chu, W.-C. / Lan, K.-H. / Li, C.-P. / Chao, Y. / Lin, H.-C. / Lee, S.-D. / Tsai, Y.-C. / Lee, W.-P. et al. | 2012
- 3475
-
Transforming growth factor- beta 1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasionWang, Y. / Lui, W.-Y. et al. | 2012
- 3488
-
Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell linesFan, P. / McDaniel, R.E. / Kim, H.R. / Clagett, D. / Haddad, B. / Jordan, V.C. et al. | 2012
- 3499
-
Correlation between Ki-67 immunohistochemistry and 18F-Fluorothymidine uptake in patients with cancer: A systematic review and meta-analysisChalkidou, A. / Landau, D.B. / Odell, E.W. / Cornelius, V.R. / O Doherty, M.J. / Marsden, P.K. et al. | 2012
- S1
-
AOSOP3 Combination of bevacizumab and erlotinib in the treatment of patients with advanced hepatocellular carcinoma with sorafenib-refractory disease: Results of a pilot phase II studyYau, T. / Wong, H. / Chan, P. / Yao, T. J. / Cheung, T. T. / Fan, S. T. / Poon, R. T. et al. | 2012
- S1
-
PG 1.03 Neoadjuvant treatment: Do we need radiotherapy?Glynne-Jones, R. et al. | 2012
- S2
-
E1. What the past is telling us about the futureCosta, A. et al. | 2012
- S3
-
AOS1 Pilot cancer screening programme on wheels in MumbaiKumar, Y. / Mishra, G. / Gupta, S. / Shastri, S. S. et al. | 2012
- S3
-
PG 4.02 Pancreatic surgery: Beyond the traditional limitsSchmied, B. / Muller, S. / Tarantino, I. et al. | 2012
- S4
-
AOS4 Detection of human papillomavirus DNA in patients with different cervical lesions in Kurdistan region, IraqAli, K. S. / Jubrael, J. M. S. / Ali, H. Y. M. et al. | 2012
- S4
-
PG 4.04 Radiochemotherapy of the pancreas: State of the art 2012Mornex, F. / Diaz, O. / Enachescu, C. et al. | 2012
- S4
-
E2. Controversial issues in the surgical management of the elderly breast cancer patientBastiaannet, E. / van de Water, W. / Liefers, G. J. / van de Velde, C. J. H. et al. | 2012
- S5
-
PG 6.01 Who is a candidate for endoscopic surgery?Oyama, T. et al. | 2012
- S5
-
AOS7 Role of cryotherapy in multidisciplinary management of endobronchial metastasesEaton, D. / Beeson, J. / Maiwand, O. / Anikin, V. et al. | 2012
- S6
-
AOS10 Prognostic factors for patients with leptomeningeal metastases from solid tumoursKwon, J. / Chie, E. K. / Kim, K. / Kim, H. J. / Wu, H. G. / Kim, I. H. / Oh, D. Y. / Lee, S. H. / Kim, D. W. / Im, S. A. et al. | 2012
- S6
-
PG 6.03 Criteria for selecting the best multimodial therapyHolscher, A. H. et al. | 2012
- S6
-
E3. What is Hot in breast cancer radiation oncology in 2012?Poortmans, P. / Orecchia, R. et al. | 2012
- S7
-
AOS12 Efficacy and safety of trabectedin versus gemcitabine/docetaxel in patients with sarcoma after failure of anthracycline and/or ifosfamideAdam, K. / Farid, M. / Sairi, A. / Widayana, H. / Manaf, A. / Soh, L. / Quek, R. et al. | 2012
- S8
-
E4. Current issues in breast cancer screeningWilson, A. R. M. / Nystrom, L. / Paci, E. / Gilbert, F. / Mann, R. et al. | 2012
- S8
-
PG 8.01 Writing and submitting an outstanding scientific manuscriptHaller, D. G. et al. | 2012
- S8
-
AOS14 Phase II clinical study of combination chemotherapy with herb Withania somnifera (ashwagandha) in breast cancerBiswal, B. M. / Sulaiman, A. M. / Ismail, H. C. / Zakaria, H. / Jalil Abdul, M. I. / Muhammad, K. I. et al. | 2012
- S9
-
PG 9.03 Can adjuvant radiochemothrapy replace extended lymph node dissection?Jansen, E. P. M. et al. | 2012
- S9
-
AOS17 KRAS genotypes in Thai patients with colorectal cancerAutkittanon, P. / Reukumneuychok, B. / Limsuwanachot, N. / Ativitavas, T. / Sirisinha, T. / Panvichian, R. / Ratanatharathorn, V. / Sirachainan, E. et al. | 2012
- S10
-
PG 10.03 Lessons from the GASTRIC metaanalysis of adjuvant treatmentRougier, P. et al. | 2012
- S10
-
AOS21 Role of PET/CT in patients with occult primary cancer with neck metastasisMohindra, S. / Bhattacharya, A. / Ghoshal, S. et al. | 2012
- S11
-
E5. SenoNetwork^@?: Expanding frontiers and reflecting patterns of breast cancer care around the worldGarcia-Etienne, C. A. et al. | 2012
- S11
-
AOS24 Cancer physicians' attitudes towards cancer treatment in geriatric patients in SingaporePang, A. / Ho, S. / Lee, S. C. et al. | 2012
- S12
-
AOS27 Extensive juvenile nasopharyngeal angiofibroma: A long-term study of 40 patients successfully treated with radiotherapyMaheshwari, G. K. et al. | 2012
- S13
-
03 Extracapsular lymph node spread: not-so-well known but important prognostic factor in gastric cancerPicchetto, A. / Aurello, P. / Catracchia, V. / Petrucciani, N. / D'Angelo, F. / Uccini, S. / Ramacciato, G. et al. | 2012
- S13
-
E6. Can an international consensus meeting change the future of advanced breast cancer patients? Highlights from ABC1 Consensus MeetingCardoso, F. / Winer, E. / Norton, L. / Gomis, R. / Krop, I. / Harbeck, N. / Costa, A. et al. | 2012
- S14
-
07 Serum tryptase as a new biomarker in colorectal cancer patientsAmmendola, M. / Patruno, R. / Ruggieri, E. / Coviello, M. / Di Lecce, V. / Vacca, A. / Sacco, R. / Montemurro, S. / Gadaleta, C. D. / Ranieri, G. et al. | 2012
- S15
-
11 Use of IHC and DISH of EGFR to evaluate efficacy of anti-EGFR drugs in KRAS-WT patients with mCRCTakahashi, N. / Yamada, Y. / Taniguchi, H. / Akiyoshi, K. / Honma, Y. / Iwasa, S. / Kato, K. / Hamaguchi, T. / Shimada, Y. et al. | 2012
- S15
-
E7. Where do we stand in advanced breast ultrasound?Mundinger, A. / Wilson, A. R. M. / Weismann, C. / Rizzatto, G. / Mendelson, E. B. / Madjar, H. / Durante, E. et al. | 2012
- S18
-
E8. Clinical applications of circulating tumour cellsRack, B. / Andergassen, U. / Neugebauer, J. / Jager, B. / Janni, W. et al. | 2012
- S20
-
E9. Oncoplastic Surgery: increasing surgical options for breast cancer patientsRubio, I. T. et al. | 2012
- S22
-
E10. Issues around hereditary breast cancer and local treatmentOldenburg, H. et al. | 2012
- S24
-
E11. The tumour microenvironment in breast cancerWerb, Z. et al. | 2012
- S26
-
E12. Managing toxicity of aromatase inhibitors in early breast cancerLintermans, A. / Paridaens, R. / Neven, P. et al. | 2012
- S28
-
E13. Hypofractionated radiotherapy for breast cancerYarnold, J. et al. | 2012
- S32
-
E16. Clinical implications of microRNAs in breast cancerMoretti, E. / Guarducci, C. / Paladini, L. / Di Leo, A. / Santarpia, L. et al. | 2012
- S42
-
8 Overview of Mechanism of Resistance in Hormonal TherapyMalorni, L. et al. | 2012
- S43
-
13 No Axillary Surgery in Breast Cancer?Alran, S. / Ngo, C. / Reyal, F. / Fourchotte, V. / Tardivon, A. / Pierga, J. Y. / Salomon-Vincent, A. / Fourquet, A. et al. | 2012
- S48
-
28 The Effects of Population-based Mammography Screening Starting Between Age 40 and 50 Compared to the Effects of Adjuvant Systemic Therapyde Gelder, R. / Heijnsdijk, E. A. M. / Fracheboud, J. / Draisma, G. / de Koning, H. J. et al. | 2012
- S49
-
31 Strategies for Increasing Early Detection of Breast Cancer Through Community Outreach and TrainingAddai, B. W. et al. | 2012
- S51
-
38 The Effects of Internet Based Patient Education in the Field of Breast Cancer - a Systematic Literature ReviewRyhanen, A. M. / Rankinen, S. / Siekkinen, M. / Korvenranta, H. / Leino-Kilpi, H. et al. | 2012
- S52
-
41 Quality of Life Assessment Through the EORTC Questionnaires, in Elderly Women with Breast Cancer Treated with Radiotherapy - A Prospective StudyDominguez, M. A. / Arraras, J. I. / Manterola, A. / Asin, G. / Zarandona, U. / Rico, M. / Eito, C. / Chicata, V. / Villafranca, E. / Arias, F. et al. | 2012
- S54
-
49 Breast Cancer in Patients 40 Years Old or Younger Treated at the Department of Radiation Oncology of CHU OranBoukerche, A. / Madouri, R. / Belmiloud, H. / Benarbia, M. / Yahia, A. / Dali-Youcef, A. F. et al. | 2012
- S55
-
52 Surgery Treatment Improves Breast Specific Survival in Elderly Patients with Early Stage of Breast CancerCortadellas, T. / Gascon, A. / Cordoba, O. / Esgueva, A. / Espinosa, M. / Xercavins, J. / Rubio, I. t. et al. | 2012
- S56
-
55 Clinicopathological Pattern and Mammaglobin Immunohistochemistry as a Prognostic Marker in Breast Carcinomas Presenting in Young Pakistani WomenNaseem, N. / Nagi, A. H. / Rehman, F. / Anwar, S. et al. | 2012
- S57
-
58 Presentation and Outcomes of Breast Cancer in Asian Women Under 40: Misdiagnosis or Misfortune?Chuwa, E. / Teo, S. Y. / Lew, Y. L. / Ong, C. L. / Hong, G. S. et al. | 2012
- S58
-
61 Functionalized and Structured Medical Wire as a Device for In-vivo Isolation of Circulating Tumor Cells in Breast Cancer PatientsNowaczyk, P. / Herold, S. / Kim, P. S. / Schmitz, A. / Polom, K. / Murawa, P. / Morgenthaler, N. G. / Zabel, M. / Luecke, K. / Murawa, D. et al. | 2012
- S59
-
65 Trends in and Pattern of Breast Diseases Diagnosed by Core Needle Biopsy - an 8-years Experience of a Breast UnitLienart, V. / Sirtaine, N. / Van Beveren, M. / Fontaine, D. / Carly, B. / Cusumano, P. / Fastrez, M. / Beier, B. / Jeanjot, I. / Liebens, F. et al. | 2012
- S60
-
68 18F-FDG PET-CT Compared to Conventional Staging Procedures in Patients with Advanced Breast CarcinomaFris, J. H. A. / Duchateau, C. S. J. / van Gils, A. P. G. / Merkus, J. W. S. et al. | 2012
- S61
-
72 Identification of Sentinel Lymph Node Metastasis and Axillary Status in Early Breast Cancer by Indocyanine Green Fluorescence MethodSugie, T. / Sawada, T. / Tagaya, N. / Kinoshita, T. / Yamagami, K. / Suwa, H. / Yoshimura, K. / Nimi, M. / Toi, M. et al. | 2012
- S64
-
83 The Characteristics of Primary Breast Cancers with Non Mass like Enhancements in a Breast MRILee, J. / Jeon, C. W. / Lee, W. I. / Kim, S. J. et al. | 2012
- S67
-
92 Lipid Profiling of Benign and Cancerous Breast Tissues by 1H NMR Spectroscopy in Indian FemalesArshad, F. / Sonkar, K. / Sinha, N. et al. | 2012
- S68
-
95 Correlating Breast Density Measured by MRI and Diffuse Optical Spectroscopic Imaging During Neoadjuvant ChemotherapyLeproux, A. / O'Sullivan, T. D. / Chen, J. H. / Nalcioglu, O. / Su, M. Y. L. / Tromberg, B. J. et al. | 2012
- S69
-
99 Free Hand Breast Core Biopsies in a Selected Group Are as Good as Image Guided BiopsiesParvaiz, M. A. / Ismail, A. / Fussey, J. / Isgar, B. et al. | 2012
- S70
-
102 Completion Axillary Dissection Can Safely Be Omitted in Screening Detected Breast Cancer Patients with Micrometastases in the Sentinel Node BiopsyRyden, L. / Dihge, L. / Ferno, M. / Ingvar, C. / Grabau, D. et al. | 2012
- S71
-
105 Do We Need to Biopsy Young Women with Clinically and Radiologically Benign Breast Lumps?Goonetilleke, K. / Vijayan, D. / Sharma, N. / Virdee, K. / Sintler, M. et al. | 2012
- S74
-
117 An Early Experience with SNOLL in the Management of Impalpable Breast CancerGalea, M. / Ramesh, H. S. J. / Chagla, L. S. / Ray, A. / Herbert, J. / Harris, O. / Desmond, S. / Thind, R. / Audisio, R. A. et al. | 2012
- S75
-
121 Risk Factors Associated with Lobular Carcinoma in Situ: Results of the GLACIER StudySawyer, E. / Petridis, C. / Kohut, K. / Gorman, P. / Caneppele, M. / Roylance, R. et al. | 2012
- S77
-
127 Korean Hereditary Breast Cancer (KOHBRA) StudyKang, E. / Kim, D. / Yom, C. K. / Kim, S. W. / Ahn, S. H. / Park, S. K. / Lee, M. H. / Noh, W. C. / Noh, D. Y. / Korean Breast Cancer Study et al. | 2012
- S78
-
131 Mammographic Density, Tumor Characteristics, and PrognosisEriksson, L. / Czene, K. / Rosenberg, L. / Humphreys, K. / Hall, P. et al. | 2012
- S79
-
135 Preliminary Results of a Medical Unit for Prevention-consultation of Familial and Hereditary Breast CancerTsoukalas, N. / Tryfonopoulos, D. / Lypas, G. / Papadimitriou, C. / Pistamalntzian, N. / Panopoulos, C. / Demiri, S. / Koumakis, G. / Barbounis, V. / Efremidis, A. et al. | 2012
- S82
-
146 Huge Decrease in Risk of Breast Cancer Relapse in the Netherlands over the Last 3 DecadesGeurts, S. M. E. / van Dijck, J. A. A. M. / de Vegt, F. / Paquay, Y. / Siesling, S. / Verbeek, A. L. M. / Tjan-Heijnen, V. C. G. et al. | 2012
- S83
-
150 Optimal Age to Start Preventive Measures in Women with BRCA1/2 Mutations or High Familial Breast Cancer RiskTilanus-Linthorst, M. M. A. / Lingsma, H. / Evans, D. G. / Kaas, R. / Manders, P. / Hooning, M. J. / van Asperen, C. J. / Oosterwijk, J. C. / Leach, M. O. / Steyerberg, E. J. et al. | 2012
- S85
-
157 Contra-lateral Breast Cancer - A 5 Year Clinical StudyShankar, A. / Mahajan, M. K. / Sachdev, J. / Jeyaraj, P. et al. | 2012
- S86
-
161 Breast Cancer in Ethiopia: the Addis Ababa-Halle University Collaboration Project Studying Incidence, Mortality and Clinical EpidemiologyKantelhardt, E. J. / Fuehrer, A. / Breitenstein, E. / Zerche, P. / Trocchi, P. / Adamu, A. / Tufa, G. / Stang, A. / Thomssen, C. / Bogale, S. et al. | 2012
- S87
-
164 Five-year Survival and Prognostic Factors in a Cohort of Breast Cancer Patients Treated in Brazilian National Cancer Institute, Rio De Janeiro, BrazilBello, M. / Millen, E. C. / Carmo, P. A. O. / Motta, R. C. / Thuler, L. C. S. / Bergmann, A. et al. | 2012
- S88
-
167 The Clinical Features and Prognosis of Tubular Breast CancerIzquierdo, M. / Tresserra, F. / Rodriguez, I. / Fabregas, R. / Cusido, M. / Ara, C. / Baulies, S. et al. | 2012
- S90
-
175 Clinicopathological Pattern and Prognostic Influence of Neuroendocrine Differentiation in Breast CarcinomasNaseem, N. / Nagi, A. H. / Rehman, F. / Anwar, S. et al. | 2012
- S91
-
178 Histopathological Grading of Ductal Carcinoma in Situ of the Breast - Validation of a Web-based Survey Through Intraobserver Reproducibility AnalysisSchuh, F. / Biazus, J. V. / Resetkova, E. / Benfica, C. Z. / Ventura, A. F. / Uchoa, D. / Graudenz, M. / Edelweiss, M. I. et al. | 2012
- S94
-
188 Efficacy and Safety of Lapatinib Treatment in Trastuzumab Pretreated Patients with HER2 Positive Metastatic Breast Cancer - An Analysis of IntERB Registry in the Czech RepublicGrell, P. / Kandrnal, V. / Bortlicek, Z. / Vyzula, R. et al. | 2012
- S95
-
191 DETECT III - a Multicenter, Randomized, Phase III Study to Compare Standard Therapy Alone Versus Standard Therapy Plus Lapatinib in Patients with Initially HER2-negative Metastatic Breast Cancer and HER2-positive Circulating Tumor CellsMelcher, C. A. / Janni, W. / Rack, B. / Muller, V. / Schneeweiss, A. / Pantel, K. / Solomayer, E. F. / Aktas, B. / Fasching, P. / Fehm, T. et al. | 2012
- S102
-
202 Imaging and targeting the drivers of invasion and metastasisFrame, M. / Serrels, A. / Serrels, B. / Canel, M. / Sandilands, E. / Patel, H. / Brunton, V. et al. | 2012
- S104
-
211 Phase III Trial (EORTC 10801) Comparing Breast-conserving Therapy with Radical Mastectomy - Twenty Year Follow-up ResultsLitiere, S. / Werutsky, G. / Fentiman, I. S. / Rutgers, E. / Christiaens, M. R. / Van Limbergen, E. / Baaijens, M. H. A. / Bogaerts, J. / Bartelink, H. et al. | 2012
- S105
-
215 Radiotherapy in Relation to BiologyChua, B. H. et al. | 2012
- S106
-
218 External Barries to Effective Care in Clinical ResearchPugliano, L. / Piccart, M. et al. | 2012
- S109
-
230 A Phase II Study of Pegylated Liposomal Doxorubicin Combined with Cyclophosphamide / 5-fluorouracil as Second Line Chemotherapy in Patients with Metastatic Breast Cancer Who Failed Previous Taxane-based TreatmentChang, H. K. / Lin, Y. C. / Rau, K. M. / Chen, Y. Y. / Lee, K. D. / Wang, C. H. et al. | 2012
- S110
-
233 Tartrate-resistant Acid Phosphatase and C-terminal Telopeptide of Type I Collagen as Serum Tumor Markers in Women with Bone Metastases From Breast CancerLumachi, F. / Marino, F. / Basso, U. / Chiara, G. B. / Basso, S. M. M. et al. | 2012
- S111
-
236 Bone Management by Bisphosphonate in Metastatic Breast Cancer PatientsWatanabe, J. / Kubo, Y. / Ogiya, A. / Tadokoro, Y. / Tanaka, K. / Nishikawa, N. / Sato, M. / Takahashi, K. et al. | 2012
- S112
-
241 Bone Marrow Micrometastases in Breast Cancer. Changes in Hematologic ParametersRodionova, M. / Rodionov, V. / Bogomolova, O. / Bayramov, A. et al. | 2012
- S113
-
245 Incorporating Epithelial Mesenchymal Plasticity (EMP) in the Detection and Isolation of Circulating and Disseminated Tumour CellsJacobsen, N. / Dobrovic, A. / Tachtsidis, A. / Blick, T. / Thomas, E. / Dowling, A. / Huang, D. / Zeps, N. / Saunders, C. / Thompson, E. et al. | 2012
- S115
-
251 Retrospective Analysis of the Relative Efficacy and Toxicity of Nab-paclitaxel and Docetaxel in Metastatic Breast CancerHowell, S. J. / Armstrong, A. C. / Ashcroft, L. et al. | 2012
- S116
-
254 Oral Combination Chemotherapy with Capecitabine and Cyclophosphamide Showed Good Efficacy and Quality of Life for Metastatic Breast Cancer PatientKameshima, H. / Ohmura, T. / Kutomi, G. / Shima, H. / Takamaru, T. / Satomi, F. / Suzuki, Y. / Hirata, K. / Otokozawa, S. et al. | 2012
- S118
-
261 Efficacy of Aromatase Inhibitors in Male Breast Cancer n a Single Centre ExperienceStevens, R. et al. | 2012
- S119
-
264 Mitochondrial DNa Mutations and Copy Number Alteration in Breast Cancer Patients From RomaniaRusanu, C. / Botezatu, A. / Iancu, I. / Huica, I. / Plesa, A. / Anton, G. et al. | 2012
- S120
-
268 Analysis of Large Genomic Rearrangements of BRCA1/2 Genes in Korean Breast Cancer PatientsSon, B. H. / Ahn, S. H. / Lee, J. W. / Yu, J. H. / Kim, H. J. / Ko, B. S. / Cho, J. Y. / Ku, B. K. / Cho, D. Y. et al. | 2012
- S121
-
271 Quantitative Analysis of RORalpha mRNA Expression in Human Breast CancerOdawara, H. O. / Horighchi, J. H. / Iwasaki, T. I. / Rokutanda, N. R. / Nagaoka, R. N. / Tokiniwa, H. T. / Sato, A. S. / Koibuchi, Y. K. / Koibuchi, N. K. / Takeyoshi, I. T. et al. | 2012
- S122
-
274 Correlation of CD10 and EGFR Expression in Phyllodes Tumors of the BreastKim, J. / Kim, R. / Kim, K. / Jung, Y. / Soh, E. / Yim, H. / Chun, M. et al. | 2012
- S124
-
281 Quantitative Assessment of Her-2 Expression of Circulating Tumor Cells in Patients with Metastatic and Non Metastatic Breast CancerBidard, F. C. / Ligthart, S. T. / Pierga, J. Y. / Terstappen, L. W. M. M. et al. | 2012
- S125
-
285 Differences in MicroRNA Expression Pattern Predetermine Receptor Phenotypes of Breast Cancer CellsHalytskiy, V. et al. | 2012
- S126
-
288 Changes in Estrogen Receptor (ER), Progesterone Receptor (PgR) and HER2/neu Status During Primary Systemic Chemotherapy in Breast CancerTozuka, K. / Horiguchi, J. / Takata, D. / Rokutanda, N. / Nagaoka, R. / Tokiniwa, H. / Kikuchi, M. / Satou, A. / Takeyoshi, I. et al. | 2012
- S128
-
297 Efficacy and Safety of Fetal Human Estrogen Estetrol (E4) in Women with Estrogen-receptor Positive Early Breast CancerSinger, C. / Natter, C. / Steurer, S. / Rudas, M. / Moinfar, F. / Appels, N. R. C. A. / Visser, M. / Kubista, E. / Bennink, H. J. T. C. et al. | 2012
- S129
-
300 Comparison of Frequencies and Prognostic Effect of Molecular Subtypes Between Young and Elderly Breast Cancer PatientsDe Kruijf, E. / Bastiaannet, E. / Ruberta, F. / SOrlie, T. / de Craen, A. J. M. / Kuppen, P. J. K. / Smit, V. / van de Velde, C. J. H. / Liefers, G. J. et al. | 2012
- S130
-
303 Could the Axilla Be Managed Less Aggressively in Selected Node-positive Breast Cancer Patients?Walker, G. A. / Rakha, E. / Cheung, K. L. / Morgan, D. A. L. et al. | 2012
- S131
-
306 The Influence of Education Level On the Survival of Breast CancerHwang, K. T. / Han, W. / Shin, H. C. / Kang, H. S. / Bae, Y. T. / Jung, Y. S. / Koh, S. H. / Noh, D. Y. et al. | 2012
- S132
-
309 PR Negative Tumors n Prognosis and Results of Oncotype DxShai, A. / Rabkin, A. / Sikorsky, N. / Steiner, M. et al. | 2012
- S134
-
316 Prognostic Role of Preoperative Serum CA15.3 and Its Association with Clinicopathological ParametersDragoumis, D. / Desiris, K. / Christopoulos, P. / Assimaki, A. / Tsiftsoglou, A. et al. | 2012
- S135
-
319 Clinical Dilemmas in Bilateral Breast CancerTang, S. / Hartman, M. / Yun, E. / Sandberg, M. / Chia, K. S. / Czene, K. / Verkooijen, H. M. et al. | 2012
- S138
-
328 Prognostic and Predictive Factors in Breast Cancer Relapse. Long-term Retrospective Study in a Cohort of Patients with Invasive Ductal CarcinomaLumachi, F. / Marino, F. / Tozzoli, R. / Santeufemia, D. A. / Chiara, G. B. / Basso, S. M. M. et al. | 2012
- S139
-
332 Evaluation of Molecular Parameters and Risk Factors of Breast Cancer in Therapeutic DecisionsSoares, R. / Shvets, Y. / Afonso, N. / Rodrigues, H. et al. | 2012
- S142
-
343 Risk Factors of Breast Cancer Relapse. a Case-control Study and Results of Multivariate Analysis in a Cohort of 348 Patients Who Underwent Curative SurgeryLumachi, F. / Marino, F. / Santeufemia, D. A. / Lo Re, G. / Tumolo, S. / Chiara, G. B. / Basso, S. M. M. et al. | 2012
- S149
-
366 Use of Complementary and Alternative Medicine by Breast Cancer PatientsMartens, M. H. / van Roozendaal, L. M. / Schouten, L. J. / Hermans, J. J. R. / Bast, A. / Weijenberg, M. P. / Smidt, M. L. et al. | 2012
- S150
-
370 Lifestyle and Change in Bone Mineral Density in Japanese Postmenopausal Women with Hormone Receptor-positive Breast Cancer Before and After 1 Year of Aromatase Inhibitor TreatmentNishimura, R. / Yamaguchi, M. / Watanabe, R. / Toh, U. / Koga, K. / Shirahane, K. / Yoshinaga, Y. / Sasaki, H. / Tamura, K. / Mitsuyama, S. et al. | 2012
- S151
-
374 Anxiety Disorder and Major Depressive Disorder in Women with Breast Cancervan Esch, L. / Roukema, J. A. / de Vries, J. et al. | 2012
- S152
-
377 Perceptions of Fertility and Risk in Young Breast Cancer PatientsLee, R. / Foy, S. / Armstrong, A. et al. | 2012
- S154
-
384 Ipsilateral Hemodialysis Access After Axillary Dissection for Breast CancerOlsha, O. / Man, V. / Carmon, M. / Shemesh, D. et al. | 2012
- S155
-
388 The Value of Patient-reported Outcomes in the Management of Women with Breast CancerNikitina, T. / Kurbatova, K. / Ionova, T. / Novik, A. et al. | 2012
- S158
-
398 Fat Necrosis Frequency and Evaluation After Oncoplastic SurgeryLee, J. J. / Nam, K. H. / Kim, W. W. / Jung, J. H. / Park, H. Y. / Yang, J. D. / Lee, Y. H. et al. | 2012
- S159
-
401 Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors or TamoxifenLintermans, A. / Dieudonne, A. S. / Vanderhaegen, J. / Henry, N. L. / Wildiers, H. / Paridaens, R. / Christiaens, M. R. / Smeets, A. / Leunen, K. / Neven, P. et al. | 2012
- S160
-
405 Triple Negative Breast Cancer: Perceptions of Prognosis, Psychological Impact and Care NeedsGlendenning, J. / Pederson, V. / Shewbridge, A. / Tutt, A. / Richardson, A. / Armes, J. et al. | 2012
- S166
-
413 Relationship Between Body Mass Index (BMI) and Outcomes in Node-positive Breast Cancer Patients Receiving Chemotherapy-Results From CALGB/Intergroup 9741Ligibel, J. / Cirrincione, C. / Citron, M. / Ingle, J. / Gradishar, W. / Martino, S. / Hudis, C. / Winer, E. / Berry, D. et al. | 2012
- S167
-
416 An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)Campa, D. / Kaaks, R. / Le Marchand, L. / Haiman, C. A. / Travis, R. / Ziegler, R. G. / Hunter, D. J. / Lindstrom, S. / Canzian, F. et al. | 2012
- S169
-
422 Final Safety Data From a Randomised Phase III Trial (CIBOMA/2004-01_GEICAM/2003-11) Assessing Adjuvant Capecitabine Maintenance Therapy After Standard Chemotherapy for Triple-negative Early Breast Cancer. a Study From Coalicion Iberoamericana De Investigacion En Oncologia Mamaria (CIBOMA) and Grupo Espanol De Investigacion En Cancer De Mama (GEICAM)Lluch, A. / Ruiz-Borrego, M. / Barrios, C. H. / Bines, J. / Torrecillas, L. / Segalla, J. G. / Ruiz, A. / Garcia-Saenz, J. A. / Torres, R. / Martin, M. et al. | 2012
- S170
-
425 Prognostic Factors for Triple Negative Breast Cancer Patients with Preoperative Systemic ChemotherapyAsaga, S. / Kinoshita, T. / Hojo, T. / Suzuki, J. / Jimbo, K. / Tsuda, H. et al. | 2012
- S172
-
432 Comparison of Efficiency and Side Effect of Adriamycin and Doxetaxel and Adriamycin, Cyclophosphamide and Paclitaxel in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant ChemotherapyHong, W. / Kim, K. / Jung, Y. / Kim, J. / Kang, S. / Chun, J. / Chun, M. / Yim, H. / Kang, D. / Kim, T. et al. | 2012
- S173
-
435 Genetic Variability in the Methylenetetrahydrofolate Reductase (NAD(P)H) Gene (MTHFR) is Associated with Severe Non Hematological Toxicity of Adjuvant FEC in Breast CancerVulsteke, C. / Lambrechts, D. / Dieudonne, A. S. / Hatse, S. / Brouwers, B. / Van Brussel, T. / Neven, P. / Belmans, A. / Paridaens, R. / Wildiers, H. et al. | 2012
- S174
-
438 Primary Systemic Therapy for Hormone-sensitive Breast Cancer-in View of Ki-67 Labeling IndexKochi, M. / Matsumi, Y. / Ito, M. / Ohtani, S. / Higaki, K. et al. | 2012
- S177
-
449 Febrile Neutropenia (FN) in Early Breast Cancer Patients Receiving FEC-D - the Effect of Moving to Primary Granulocyte-colony Stimulating Factor (G-CSF) in the Mersey and Cheshire Cancer NetworkMullard, A. P. / O'Reilly, S. M. / Ali, Z. / Schofield, P. S. / Malik, Z. M. / Wong, H. C. et al. | 2012
- S178
-
452 Development and Validation of Nomogram to Predict Postoperative Invasive Component in Ductal Carcinoma in Situ at Core Needle BiopsyChang, M. C. / Min, J. W. / Kim, D. U. / Oh, S. H. / Kim, Y. M. et al. | 2012
- S179
-
456 Open Controversies and Guidelines of the European Institute of Oncology (IEO, Milan) On the Management of Ductal Intraepithelial Neoplasia (DIN)Lissidini, G. / Farante, G. / Viale, G. / Del Castillo, A. / Caldarella, P. / Curigliano, G. / Veronesi, P. / Luini, A. / Zurrida, S. et al. | 2012
- S180
-
459 Pre-operative CT Scan in Breast Conserving Therapy for Determination of the Boost Volume for Radiotherapyvan den Assem, M. B. / Visser, J. / Zonderland, H. M. / van Tienhoven, G. / Crama, K. F. / Bijker, N. et al. | 2012
- S182
-
466 Benefit of Different Radiation Boost Dose Based on Surgical Margins - Single-institution Experience on 2 173 Patients Treated with Radiotherapy After Breast-conserving SurgeryMeattini, I. / Livi, L. / Saieva, C. / Scotti, V. / Franceschini, D. / Desideri, I. / Sanchez, L. / Bianchi, S. / Orzalesi, L. / Biti, G. et al. | 2012
- S183
-
470 Retrospective Analysis of Postmastectomy Adjuvant Radiotherapy in Patients with Less Than Four Axillary Lymph NodesSaha, S. / Chatterjee, S. / Sarkar, S. / Deb, S. et al. | 2012
- S184
-
473 The Role of VEGF Gene Polymorphisms in the Development of Distant Metastases in Postmenopausal Breast Cancer PatientsKrenn-Pilko, S. / Hofmann, G. / Renner, W. / Gerger, A. / Thurner, E. M. / Kapp, K. S. / Langsenlehner, U. / Langsenlehner, T. et al. | 2012
- S185
-
477 Feasibility Study On Pre-operative MRI-guided Irradiation in Breast-conserving Therapyden Hartogh, M. D. / Philippens, M. E. P. / Blanken, N. / van Vulpen, M. / van Asselen, B. / van den Bongard, H. J. G. D. et al. | 2012
- S186
-
480 Improved Cosmetic Outcome After TARGIT Compared with External Beam Radiotherapy for Early Breast CancerKeshtgar, M. / Williams, N. R. / Corica, T. / Saunders, C. / Bulsara, M. / Joseph, D. et al. | 2012
- S187
-
484 Late Radiation Toxicity After Intraoperative Radiotherapy (IORT) for Breast Cancer: Results From the Randomized Phase III Trial TARGIT ASperk, E. / Welzel, G. / Keller, A. / Kraus-Tiefenbacher, U. / Gerhardt, A. / Sutterlin, M. / Wenz, F. et al. | 2012
- S188
-
488 Comparison Between Two Radiation Planning Techniques for the Breast Boost in Patients Who Underwent Neoadjuvant Chemotherapy for Breast CancerNardone, L. / De Santis, M. C. / Diletto, B. / D' Agostino, G. R. / Mattiucci, G. / Canna, R. / Terribile, D. / Franceschini, G. / Mule, A. / Valentini, V. et al. | 2012
- S189
-
491 Medical and Personal Reasons of No Breast Reconstruction After Mastectomy - Results in 1937 Breast Cancer Patients with 70% of No Reconstruction in a Single Cancer InstituteHequet, D. / Zarca, K. / Dolbeault, S. / Couturaud, B. / Reyal, F. / De La Rochefordiere, A. / Sigal, B. / Asselain, B. / Hajage, D. / Alran, S. et al. | 2012
- S190
-
494 Sentinel Node Biopsy in Extensive Ductal Carcinoma in Situ (DCIS) Results of the French Prospective Trial CINNAMOMEde Lara, C. T. / Giard, S. / Baron, M. / Le-Bouedec, G. / Garbay, J. R. / Blanchot, J. / Mollard, J. / Charitansky, H. / Martin-Francoise, S. et al. | 2012
- S191
-
497 Systematic Review: Immediate vs Delayed Breast Reconstruction Post-mastectomyD'Souza, N. / Darmanin, G. / Fedorowicz, Z. et al. | 2012
- S192
-
501 The Additional Value of Blue Dye for Sentinel Lymph Node Detection in Breast Cancer Patients, in Comparison to LymphoscintigraphyKorteweg, M. A. / Veldhuis, W. B. / Hobbelink, M. G. G. / Stehouwer, B. L. / van den Bosch, M. A. A. J. / Witkamp, A. J. / van Diest, P. J. / Mali, W. / van Amstel, J. et al. | 2012
- S193
-
504 Observational Study and Evaluation of Blue Dye-assisted Axillary Node Sampling for Axillary Staging in Early Breast CancerShaheed, S. / Ugolini, F. / Yelland, A. / Zammit, C. et al. | 2012
- S194
-
507 A Study of Clinical and Histopathologic Differences in T Stage of Breast Cancer Diagnosed at Vacuum-assisted Breast Biopsy (VABB)Park, H. L. / Kwon, S. H. / Chang, S. Y. / Huh, J. Y. / Kim, J. Y. / Shim, J. Y. / Lee, Y. H. et al. | 2012
- S195
-
511 The Oncoplastic Surgery in Large Breasted Egyptian Women with CancerDenewer, A. / Farouk, O. et al. | 2012
- S196
-
515 Early Results of an Endoscopy-assisted Nipple-sparing Mastectomy for Early Breast CancerHong, Y. / Shin, H. et al. | 2012
- S197
-
518 Sentinel Lymph Node Biopsy in Breast Cancer: the Approach in Day Surgery Under Local Anaesthesia for Quality-of-life and Effective Cost ReductionRicci, F. / Capuano, L. G. / Cosentino, C. / De Masi, C. / Dorkin, M. / Nicodemi, S. / Pacchiarotti, A. / D'Agostini, A. / Violante, A. / Scala, T. et al. | 2012
- S198
-
521 The Predictive Factor of Non-sentinel Lymph Nodes Metastases for Breast Cancer Patient with Micrometastsis and Macrometastasis in Sentinel Lymph Node OnlyKim, L. / Lim, Y. / Lee, Y. / Kim, J. / Kim, H. et al. | 2012
- S199
-
525 Can Axillary Lymph Node Dissection Be Avoided in Women with Breast Cancer with Intraoperative, False-negative Sentinel Lymph Node Biopsies?Cho, S. / Kim, D. / Lee, K. / Lee, J. / Lee, M. / Kwon, H. / Lee, H. / Lee, S. et al. | 2012
- S200
-
529 Correlation Between the Area of High-signal Intensity on SPIO-enhanced MR Imaging and the Pathologic Size of Sentinel Node Metastases in Breast Cancer Patients with Positive Sentinel NodesMotomura, K. / Nakahara, S. / Ishitobi, M. / Komoike, Y. / Koyama, H. / Inaji, H. / Horinouchi, T. / Nakanishi, K. et al. | 2012